Medical Action Industries (MDCI) Inactive 10-K/A16 Jun 142014 FY Annual report (amended)Financial data

Company Profile

Document_And_Entity_Informatio

Document And Entity Information (USD $)	12 Months Ended
Document And Entity Information (USD $)	Mar. 31, 2014	Jun. 13, 2014	Sep. 30, 2013
Document and Entity Information [Abstract]	'	'	'
Entity Registrant Name	'MEDICAL ACTION INDUSTRIES INC	'	'
Document Type	'10-K	'	'
Current Fiscal Year End Date	'--03-31	'	'
Entity Common Stock, Shares Outstanding	'	16,390,628	'
Entity Public Float	'	'	$108,834,000
Amendment Flag	'false	'	'
Entity Central Index Key	'0000748270	'	'
Entity Current Reporting Status	'Yes	'	'
Entity Voluntary Filers	'No	'	'
Entity Filer Category	'Accelerated Filer	'	'
Entity Well-known Seasoned Issuer	'No	'	'
Document Period End Date	31-Mar-14	'	'
Document Fiscal Year Focus	'2014	'	'
Document Fiscal Period Focus	'FY	'	'

Consolidated_Balance_Sheets

Consolidated Balance Sheets (USD $)	Mar. 31, 2014	Mar. 31, 2013
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Current Assets	'	'
Cash and cash equivalents	$97	$558
Accounts receivable, less allowance for doubtful accounts of $501 at March 31, 2014 and $793 at March 31, 2013	32,890	32,615
Inventories, net	32,718	53,014
Prepaid expenses	913	1,424
Deferred income taxes	1,201	1,410
Prepaid income taxes	409	1,022
Other current assets	2,649	2,295
Assets held for sale, current	61,113	'
Total Current Assets	131,990	92,338
Property, plant and equipment, net	26,161	44,960
Goodwill	19,144	30,021
Other intangible assets, net	23,737	36,586
Other assets, net	2,912	2,994
Total Assets	203,944	206,899
Current Liabilities	'	'
Accounts payable	16,456	13,523
Accrued expenses	21,924	25,106
Current portion of capital lease obligations	226	176
Current portion of long-term debt	40,112	1,370
Liabilities held for sale, current	4,200	'
Total Current Liabilities	82,918	40,175
Other long-term liabilities	1,012	595
Deferred income taxes	6,482	6,415
Capital lease obligations, less current portion	13,245	13,475
Long-term debt, less current portion	'	51,330
Total Liabilities	103,657	111,990
Stockholdersâ€™ Equity	'	'
Common stock 40,000 shares authorized, $.001 par value; issued and outstanding 16,391 shares at March 31, 2014 and March 31, 2013	16	16
Additional paid-in capital, net	36,556	35,492
Accumulated other comprehensive loss	-651	-773
Retained earnings	64,366	60,174
Total Stockholdersâ€™ Equity	100,287	94,909
Total Liabilities and Stockholdersâ€™ Equity	$203,944	$206,899

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets (Parentheticals) (USD $)	Mar. 31, 2014	Mar. 31, 2013
In Thousands, except Per Share data, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Accounts receivable, allowance for doubtful accounts (in Dollars)	$501	$793
Common stock, shares authorized	40,000	40,000
Common stock, par value (in Dollars per share)	$0.00	$0.00
Common stock, shares issued	16,391	16,391
Common stock, shares outstanding	16,391	16,391

Consolidated_Statements_of_Ope

Consolidated Statements of Operations (USD $)	12 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2012
Net sales	$287,849	$284,763	$272,734
Cost of sales	232,833	233,866	228,609
Gross profit	55,016	50,897	44,125
Goodwill impairment charge	77,780	77,780	'
Selling, general and administrative expenses	48,744	48,155	41,188
Operating income (loss)	6,272	-75,038	2,937
Interest expense, net	4,003	4,767	4,571
Income (loss) from continuing operations before income taxes and extraordinary gain	2,269	-79,805	-1,634
Income tax expense (benefit)	1,162	-21,751	283
Income (loss) from continuing operations before extraordinary gain	1,107	-58,054	-1,917
Income from discontinued operations, net of income taxes	3,085	3,198	1,643
Extraordinary gain, net of income taxes	'	'	455
Net income (loss)	$4,192	($54,856)	$181
Basic earnings (loss) per share :	'	'	'
Net income (loss) from continuing operations, before extraordinary gain (in Dollars per share)	$0.07	($3.54)	($0.12)
Net income from discontinued operations (in Dollars per share)	$0.19	$0.19	$0.10
Extraordinary gain, net of income taxes (in Dollars per share)	'	'	$0.03
Net income (loss) (in Dollars per share)	$0.26	($3.35)	$0.01
Weighted-average common shares outstanding (basic) (in Shares)	16,391	16,391	16,391
Diluted earnings (loss) per share :	'	'	'
Net income (loss) from continuing operations, before extraordinary gain (in Dollars per share)	$0.07	($3.54)	($0.12)
Net income from discontinued operations (in Dollars per share)	$0.18	$0.19	$0.10
Extraordinary gain, net of income taxes (in Dollars per share)	'	'	$0.03
Net income (loss) (in Dollars per share)	$0.25	($3.35)	$0.01
Weighted-average common shares outstanding (diluted) (in Shares)	16,466	16,391	16,391

Consolidated_Statements_of_Com

Consolidated Statements of Comprehensive Income (Loss) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2012
Net income (loss)	$4,192	($54,856)	$181
Other comprehensive income (loss), net of tax:	'	'	'
Pension and postretirement plans, unrecognized gain (loss)	122	-56	-280
Total other comprehensive income (loss), net of tax	122	-56	-280
Comprehensive income (loss)	$4,314	($54,912)	($99)

Consolidated_Statement_Of_Chan

Consolidated Statement Of Changes In Stockholders' Equity (USD $)	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Retained Earnings [Member]	Total
In Thousands, except Share data	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Retained Earnings [Member]	Total
Balance at Mar. 31, 2011	$16	$33,799	($437)	$114,849	$148,227
Balance (in Shares) at Mar. 31, 2011	16,383,000	'	'	'	'
Net income (loss)	'	'	'	181	181
Pension liability adjustment, net of income tax	'	'	-280	'	-280
Exercise of stock options, net	'	20	'	'	20
Exercise of stock options, net (in Shares)	8,000	'	'	'	-7,500
Amortization of deferred compensation	'	20	'	'	20
Tax effect from vesting/cancellation of stock under restricted management stock bonus plan and the exercise of options	'	51	'	'	51
Stock-based compensation	'	588	'	'	588
Balance at Mar. 31, 2012	16	34,478	-717	115,030	148,807
Balance (in Shares) at Mar. 31, 2012	16,391,000	'	'	'	'
Net income (loss)	'	'	'	-54,856	-54,856
Pension liability adjustment, net of income tax	'	'	-56	'	-56
Amortization of deferred compensation	'	9	'	'	9
Stock-based compensation	'	1,005	'	'	1,005
Balance at Mar. 31, 2013	16	35,492	-773	60,174	94,909
Balance (in Shares) at Mar. 31, 2013	16,391,000	'	'	'	'
Net income (loss)	'	'	'	4,192	4,192
Pension liability adjustment, net of income tax	'	'	122	'	122
Amortization of deferred compensation	'	20	'	'	20
Stock-based compensation	'	1,044	'	'	1,044
Balance at Mar. 31, 2014	$16	$36,556	($651)	$64,366	$100,287
Balance (in Shares) at Mar. 31, 2014	16,391,000	'	'	'	'

Consolidated_Statement_Of_Chan1

Consolidated Statement Of Changes In Stockholders' Equity (Parentheticals) (Accumulated Other Comprehensive Income (Loss) [Member], USD $)	12 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2012
Accumulated Other Comprehensive Income (Loss) [Member]	'	'	'
Pension liability adjustment, income tax	$35	$20	$125

Consolidated_Statements_of_Cas

Consolidated Statements of Cash Flows (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2012
Net income (loss)	$4,192	($54,856)	$181
Adjustments to reconcile net income (loss) to net cash provided by operating activities:	'	'	'
Extraordinary gain	'	'	-700
Depreciation	4,729	5,048	5,720
Amortization	4,160	3,942	4,289
Goodwill impairment charge	77,780	77,780	'
Provision for allowance for doubtful accounts	-292	15	72
Deferred income taxes	276	-21,306	2,419
Stock-based compensation	1,064	1,014	608
Excess tax benefit from stock-based compensation	'	'	-300
Gain on sale of property and equipment	-124	'	'
Tax benefit from vesting of stock under restricted management stock bonus plan and exercise of stock options	'	'	51
Changes in operating assets and liabilities:	'	'	'
Accounts receivable	16	-1,785	1,198
Inventories	1,927	811	827
Prepaid expenses and other current assets	159	-8	328
Prepaid income taxes	613	257	659
Other assets	3,871	-902	-1,185
Accounts payable	2,933	2,228	-5,774
Accrued expenses and other	-6,843	7,510	-4,380
Net cash provided by operating activities	16,681	19,748	4,013
Cash flows from investing activities:	'	'	'
Purchase price and related acquisition costs	'	'	125
Purchases of property, plant and equipment	-3,405	-1,472	-907
Proceeds from sale of property and equipment	168	4	3
Net cash used in investing activities	-3,237	-1,468	-779
Cash flows from financing activities:	'	'	'
Proceeds from revolving line of credit and long-term borrowings	232,328	90,150	105,867
Principal payments on revolving line of credit and long-term borrowings	-244,916	-113,120	-105,333
Principal payments on capital lease obligations	-180	-136	-95
Proceeds from exercise of employee stock options	'	'	20
Deferred financing costs	-1,137	'	'
Net cash provided by (used in) financing activities	-13,905	-23,106	459
Net increase (decrease) in cash and cash equivalents	-461	-4,826	3,693
Cash and cash equivalents at beginning of year	558	5,384	1,691
Cash and cash equivalents at end of year	97	558	5,384
Interest paid	2,951	4,314	4,505
Income taxes paid (refunded)	$1,559	$855	($1,304)

Note_1_Organization_and_Summar

Note 1 - Organization and Summary of Significant Accounting Policies	12 Months Ended
	Mar. 31, 2014
Accounting Policies [Abstract]	'
Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]	'
	1. ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

	COMPANY BACKGROUND AND DESCRIPTION OF BUSINESS

	Medical Action Industries Inc. (“Medical Action” or the “Company”) was incorporated under the laws of the State of New York on April 1, 1977, and re-incorporated under the laws of the State of Delaware on November 5, 1987. Headquartered in Brentwood, New York, Medical Action develops, manufactures, markets and supplies a variety of disposable medical products. The Company’s products are marketed primarily to acute care facilities throughout the United States and certain international markets, and in recent years the Company has expanded its end-user markets to include physician, dental and veterinary offices, outpatient surgery centers and long-term care facilities. Medical Action is a leading manufacturer and supplier of custom procedure trays, collection systems for the containment of medical waste, minor procedure kits and trays, disposable patient utensils, sterile operating room towels and sterile laparotomy sponges. The Company’s products are marketed by its direct sales personnel and an extensive network of health care distributors. Medical Action has entered into preferred vendor agreements with national and regional distributors, as well as sole and multi-source agreements with group purchasing organizations. The Company also offers original equipment manufacturer products under private label programs to supply chain partners and medical suppliers. Medical Action’s manufacturing, packaging and warehousing activities are conducted in its Arden, North Carolina and Toano, Virginia facilities. The Company’s procurement of certain products and raw materials from the People’s Republic of China is administered by its office in Shanghai, China. During fiscal 2014, we also conducted manufacturing, packaging and warehousing activities at our Clarksburg, West Virginia and Gallaway, Tennessee facilities. These facilities were part of the assets sold in the Patient Care business unit divestiture completed on June 2, 2014 (the "Transaction"), as disclosed in Footnote 3 – Discontinued Operations.

	All dollar amounts presented in the notes to consolidated financial statements are presented in thousands, except share and per share data.

	BUSINESS SEGMENTS AND OTHER FINANCIAL INFORMATION

	We operate as one reportable segment which is the manufacture and supply of disposable medical products. During the fiscal years ended 2014, 2013 and 2012 international sales approximated 2% of our total net sales and the net book value of our long-lived assets held outside of the United States were immaterial at March 31, 2014 and 2013.

	PRINCIPLES OF CONSOLIDATION

	The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.

	USE OF ESTIMATES

	The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, such as valuation of inventories, allowance for doubtful accounts, valuation of deferred tax assets, goodwill and other intangible assets, provision for trade rebates, pension benefits and accrued expenses, at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

	CASH EQUIVALENTS

	The Company considers all highly liquid investments with an original maturity of 90 days or less to be cash equivalents.

	ACCOUNTS RECEIVABLE, ALLOWANCE FOR DOUBTFUL ACCOUNTS AND CONCENTRATION OF CREDIT RISK

	Accounts receivable are comprised principally of trade accounts receivable that arise primarily from the sale of goods on account and are stated at historical cost. The Company performs ongoing credit evaluations on its customers and adjusts credit limits based upon payment history and the customer’s current credit worthiness, as determined by a review of their current credit information. The Company continuously monitors collections and payments from customers and a provision for estimated credit losses is maintained based upon its historical experience and on specific customer collection issues that have been identified. While such credit losses have historically been within the Company’s expectations and the provisions established, the Company cannot guarantee that the same credit loss rates will be experienced in the future. Concentration risk exists relative to the Company’s accounts receivable, net, as Owens & Minor, Inc. and Cardinal Health Inc., (the “Distributors”) accounted for approximately 60% and 64% of accounts receivable, respectively as of March 31, 2014 and 2013. While the accounts receivable related to these Distributors may be significant, the Company does not believe the credit risk to be significant given their consistent payment history.

	TRADE REBATES

	The Company provides rebates to distributors that sell to end-user customers at prices determined under a contract between the Company and the end-user customer or distributor. The Company deducts all rebates from sales and has a provision for allowances based on historical information for all rebates that have not yet been processed. The provision for trade rebates (which is included in accounts receivable) amounted to $14,331 and $14,807 at March 31, 2014 and 2013, respectively.

	INVENTORIES, NET

	Inventories are stated at the lower of cost or market net of reserve for excess, slow moving and obsolete inventory. Cost is determined by the first-in, first-out method.

	PROPERTY, PLANT AND EQUIPMENT, NET

	Property, plant and equipment are stated at cost less accumulated depreciation and amortization. Leases meeting the criteria for capitalization are recorded at the present value of future minimum lease payments. Maintenance and repairs are charged to operations as incurred and expenditures for major improvements are capitalized. The carrying amount and related accumulated depreciation of assets sold or otherwise disposed of are removed from the accounts and any resulting gain or loss is reflected in operations in the year of disposal. Accelerated methods of depreciation are used for tax purposes.

	A summary of property, plant and equipment, net, is as follows:

			March 31,
			2014				2013

	Land and buildings		$	19,079			$	29,751
	Property under capital lease			11,409				11,409
	Machinery and equipment			8,520				36,326
	Furniture and fixtures			3,161				3,351
	Computer hardware and software			1,546				2,192
	Total property, plant and equipment			43,715				83,029
	Less accumulated depreciation and amortization			17,554				38,069
	Property, plant and equipment, net		$	26,161			$	44,960

	At March 31, 2014, the Company reclassed $17,431 ($41,629 of gross carrying amount, less accumulated depreciation of $24,198) to reflect the property, plant and equipment that are included in the assets held for sale related to the Transaction, as disclosed in Footnote 3 – Discontinued Operations.

	Depreciation is calculated on the straight-line method over the estimated useful lives of the assets as follows:

		Buildings (years)		40
		Machinery and equipment (years)	5	-	20
		Furniture and fixtures (years)	3	-	10
		Computer hardware and software (years)	2	-	7

Leasehold improvements are depreciated over the shorter of the estimated useful life or the term of the lease.

Depreciation and amortization of property, plant and equipment amounted to $2,042, $2,259, and $2,890, for fiscal 2014, 2013, and 2012, respectively.

GOODWILL AND OTHER INTANGIBLE ASSETS

Goodwill and other intangible assets consist of the excess of the purchase price over the fair value of net assets acquired (goodwill) and other intangible assets (principally customer relationships, trademarks and tradenames). Values assigned to the respective assets are determined in accordance with ASC 805, Business Combinations and ASC 350, Intangibles – Goodwill and Other.

Goodwill and intangible assets with indefinite useful lives are required to be tested for impairment at least annually or more frequently if an event occurs or circumstances change that could more likely than not reduce the fair value of a reporting unit below its carrying amount. Intangible assets with estimable useful lives are required to be amortized over their respective estimated useful lives and reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable.

The Company conducts its goodwill and intangible assets with indefinite lives as of December 31 of each year. The Company assesses the impairment of its goodwill by determining its fair value and comparing the fair value to its carrying value. For goodwill impairment testing purposes, the Company has determined that it operates under one reporting unit.

The Company’s annual step one impairment testing as of December 31, 2012 indicated that the fair value of the Company was estimated to be less than its related carrying value. The fair value of the Company was estimated using a discounted cash flow and guideline company model. As a result of the step one testing, management determined that the goodwill balance of the Company was impaired and step two testing was necessary.

Step two of the goodwill test consists of performing a hypothetical purchase price allocation, under which the estimated fair value of the Company is allocated to its tangible and intangible assets based on their estimated fair values, with any residual amount being assigned to goodwill. During the step two analysis, it was determined that book value approximated fair value for the components of working capital except for finished goods and work-in-process inventory which was determined based on estimated selling prices less distribution costs and profit and costs to complete manufacture. Owned real estate and buildings were valued using recently completed real estate appraisals. Other property, plant and equipment items were valued using current market value estimates. The intangible assets related to customer relationships were valued using a present value of debt-free cash flow model and the trade names were valued using the relief-from-royalty model.

The models used to determine the fair value of the Company in step one and the intangible assets in step two relied heavily on management’s assumptions. These assumptions, which are significant to the calculated fair values, are considered Level 3 inputs under the fair value hierarchy established by ASC 820 – Fair value measurement and disclosures , as they are unobservable. The assumptions in step one included a discount rate, revenue growth rates, tax rates and operating margins. In addition, the step two assumptions included customer attrition rates and royalty rates. The discount rate represents the expected return on capital. The discount rate was determined using a target structure of 15% debt and 85% equity. The Company used the 20-year U.S. Treasury bond yield to determine the risk-free rate in its weighted average cost of capital calculation. The projected growth rates and terminal growth rates are primarily driven by management’s estimate of future performance, giving consideration to historical performance and existing and anticipated economic and market conditions. Attrition assumptions used to value customer relationships are based on historical experience and management estimates based on historical financial information. To determine the royalty rates used to value trade names, the Company used industry benchmarks from licensing transactions. The assumption for tax rates are based on management’s estimates of blended federal and state income tax rates. Operating margin assumptions are based management’s estimate of future performance, giving consideration to historical performance and projected economic and competitive conditions.

During fiscal 2013 the preliminary impairment analysis conducted at December 31, 2012 concluded that $78,609 of goodwill was impaired, which was recorded in the Company’s condensed consolidated statement of operations for the nine months ended December 31, 2012. Due to the complexity of the analysis which involved completion of fair value analyses and the resolution of certain significant assumptions, management finalized this goodwill impairment charge in the fourth quarter of fiscal 2013 by reducing the initial goodwill impairment charge by $829 to $77,780. Previous and subsequent analyses of goodwill did not indicate an impairment, therefore the amounts of impairment incurred during the fiscal year ended March 31, 2013 represent the cumulative amount of goodwill impairment charges as of March 31, 2014.

Changes in the carrying amount of goodwill were as follows:


Balance, March 31, 2012		$	107,801
Goodwill impairment charge			(77,780	)
Balance, March 31, 2013		$	30,021
Amounts reclassified to assets held-for-sale			(10,877	)
Balance, March 31, 2014		$	19,144

The book values, accumulated amortization and original useful life by asset class of the Company’s other intangible assets as of March 31, 2014 and 2013 are as follows:

						31-Mar-14								31-Mar-13
		Weighted				Gross			Accumulated			Net		Gross		Accumulated			Net
		Average				Carrying			Amortization			Carrying		Carrying		Amortization			Carrying
		Remaining				Amount						Amount		Amount					Amount
		Amortization
		Period
		(Years)
Trademarks/Tradenames not subject to amortization			na			$	569		$	-		$	569	$	1,266	$	-		$	1,266
Trademarks subject to amortization (5 years)			1.4				2,100			(1,505	)		595		2,100		(1,085	)		1,015
Customer Relationships (20 years)			16.4				27,500			(4,927	)		22,573		43,200		(8,927	)		34,273
Intellectual Property (7 Years)			na				-			-			-		400		(368	)		32
Total						$	30,169		$	(6,432	)	$	23,737	$	46,966	$	(10,380	)	$	36,586

At March 31, 2014, the Company reclassed $10,236 ($18,997 of gross carrying amount, less accumulated amortization of $8,761) to reflect the customer relationships and other intangible assets that are included in the assets held for sale related to the Transaction, as disclosed in Footnote 3 – Discontinued Operations.

The amortization expense for other intangible assets amounted to $1,795, $1,795, and $1,795 for fiscal 2014, 2013, and 2012, respectively. Estimated amortization expense related to these intangibles for the five succeeding fiscal years is as follows:

	Fiscal Year		Amount
	2015		$	1,795
	2016			1,550
	2017			1,375
	2018			1,375
	2019			1,375

The Company evaluates trademarks with indefinite lives annually to determine whether events or circumstances continue to support the indefinite useful life. No impairments of such assets were identified in fiscal 2014, 2013, and 2012. No trademarks were determined to have finite useful lives in any of the periods presented, with the exception of the trademarks acquired in the AVID acquisition, which have a useful life of 5 years.

ACCOUNTS PAYABLE

Cash overdrafts are included in accounts payable. Such cash book overdrafts amounted to $5,690 and $5,372 at March 31, 2014 and 2013, respectively. For cash flow disclosure purposes, the Company reports the cash book overdrafts as an operating activity as opposed to a financing activity.

DEFERRED FINANCING COSTS

The Company has incurred costs in obtaining financing. These costs of approximately $1,068 as of March 31, 2014 are included in other assets and are being amortized over the life of the related financing arrangements through fiscal 2019. Total accumulated amortization was approximately $240 and $882 at March 31, 2014 and 2013, respectively. In connection with the Company’s debt refinancing in May 2013 (see Footnote 8 – Long-Term Debt), the net balance of deferred financing costs associated with the Company’s prior debt was charged to operations during the twelve months ending March 31, 2014.

INCOME TAXES

We account for income taxes under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities from a change in tax rates is recognized in income in the period that includes the enactment date.

We must also assess the likelihood that deferred tax assets will be realized and, based on this assessment establish a valuation allowance, if required. The determination of our valuation allowance involves assumptions, judgments, and estimates, including forecasted earnings, future taxable income, and the relative proportions of revenue and income before taxes in the various state and local jurisdictions in which we operate. To the extent we establish a valuation allowance or change the valuation allowance in a period, we reflect the change with a corresponding increase or decrease to our tax provision in our consolidated statement of operations.

We are also required to compute our current income tax expense in each federal, state, and local jurisdiction in which we operate. Our judgments, assumptions, and estimates relative to the current provision for income tax take into account current tax laws, our interpretation of current tax laws, and possible outcomes of current and future audits. Changes in tax laws or our interpretation of tax laws and the resolution of current and future tax audits could significantly impact the amounts provided for income taxes in our consolidated balance sheet and consolidated statement of operations.

In accordance with the provisions of ASC 740, Income Taxes, we recognize in our financial statements only those tax positions that meet the more-likely-than-not-recognition threshold. For those tax positions where it is more-likely-than-not that a tax benefit will be sustained, we have recorded the largest amount of tax benefit with a greater than 50% likelihood of being realized upon settlement. For those tax positions where it is not more-likely-than-not that a tax benefit will be sustained, no tax benefit has been recognized in the consolidated financial statements. Interest and penalties associated with income tax matters are included in the provision for income taxes in our consolidated statements of operations. The provisions of ASC 740 did not have a material impact on our consolidated financial position.

CURRENCY

All of the Company’s sales and purchases were transacted in U.S. dollars.

STOCK-BASED COMPENSATION

The Company recorded stock-based compensation expense for the fair value of non-qualified stock options and restricted stock granted under its stock plans in accordance with the provisions of ASC 718, Stock Compensation.

EARNINGS (LOSS) PER SHARE INFORMATION

Basic earnings (loss) per share is based on the weighted average number of common shares outstanding without consideration of potential common stock. Diluted earnings (loss) per share is based on the weighted average number of common and potential common shares outstanding. The calculation takes into account the shares that may be issued upon exercise of stock options and restricted stock, reduced by the shares that may be repurchased with the funds received from the exercise, based on average prices during the year.

REVENUE RECOGNITION

Revenue from the sale of products is recognized when the Company meets all of the criteria specified in ASC 605, Revenue Recognition. These criteria include:

• Persuasive evidence of an arrangement exists,

• Delivery has occurred or services have been rendered,

• The seller’s price to the buyer is fixed or determinable and

• Collection of the resulting receivable is reasonably assured.

Customer purchase orders and/or sales agreements evidence the Company’s sales arrangements. These purchase orders and sales agreements specify both selling prices and quantities, which are the basis for recording sales revenue. Any deviation from this policy requires management review and approval. Trade terms are negotiated on a customer by customer basis and for the majority of the Company’s sales include that title and risk of loss pass from the Company to the customer when the Company ships products from its facilities, which is when revenue is recognized. In instances of shipments made on consignment, revenue is deferred until a customer indicates to the Company that it has used the Company’s products. The Company conducts ongoing credit evaluations of its customers and ships products only to customers that satisfy its credit evaluations. Products are shipped primarily to distributors at an agreed upon list price. Distributors then resell the products primarily to hospitals and depending on agreements between the Company, the distributors and the hospitals, the distributors may be entitled to a rebate. The Company deducts all rebates from sales and has a provision for allowances based on historical information for all rebates that have not yet been processed.

BUSINESS CONCENTRATIONS AND MAJOR CUSTOMERS

The Company manufactures and distributes disposable medical products principally to medical product distributors and hospitals located throughout the United States. The Company performs credit evaluations of its customers’ financial condition and does not require collateral. Receivables are generally due within 30 – 90 days. Credit losses relating to customers have historically been minimal and within management’s expectations.

Sales to Owens & Minor, Inc. and Cardinal Health Inc., (the “Distributors”) accounted for approximately 45% and 19% of net sales, respectively for fiscal 2014, 41% and 22% of net sales, respectively for fiscal 2013 and 44% and 22% of net sales, respectively for fiscal 2012. Although the Distributors may be deemed in a technical sense to be major purchasers of the Company’s products, they typically serve as a distributor between the end user and the Company and do not make significant purchases for their own account. The Company, therefore, does not believe it is appropriate to include the Distributors when evaluating customer concentrations.

A significant portion of the Company’s raw materials are purchased from China. All such purchases are transacted in U.S. dollars. The Company’s financial results, therefore, could be impacted by factors such as foreign currency exchange rates or weak economic conditions in foreign countries in the procurement of such raw materials should our suppliers increase prices to account for changes in foreign exchange rates.

FREIGHT AND DISTRIBUTION COSTS

Freight costs, which consist primarily of freight costs paid to third party carriers amounted to $6,323, $6,521 and $9,324 for fiscal 2014, 2013 and 2012, respectively, and are included in cost of sales. Distribution costs, which consist primarily of the salaries, warehousing and related expenses associated with the storing, packing and shipping costs of our products amounted to $3,249, $2,931 and $2,422 for fiscal 2014, 2013, and 2012, respectively, and are included in selling, general and administrative expenses.

PRODUCT DEVELOPMENT COSTS

Product development costs which are expensed as incurred were $1,171, $1,862, and $1,921 for fiscal 2014, 2013, and 2012, respectively, and are included as a component of selling, general and administrative expenses.

ADVERTISING COSTS

Advertising costs charged to expense, as incurred, were $6, $41, and $20, for fiscal 2014, 2013 and 2012, respectively.

FAIR VALUE MEASUREMENTS

We are required to record certain assets and liabilities at fair value and to make disclosures about the fair value of certain other assets and liabilities. Fair value is the price the Company would receive to sell an asset or pay to transfer a liability in an orderly transaction with a market participant at the measurement date. In the absence of active markets for identical assets or liabilities, such measurements involve developing assumptions based on market observable data and, in the absence of such data, internal information that is consistent with what market participants would use in a hypothetical transaction that occurs at the measurement date.

Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect our market assumptions. Preference is given to observable inputs. These two types of inputs create the following fair value hierarchy:

	·	Level 1 – Quoted prices for identical instruments in active markets.

	·	Level 2 – Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable.

	·	Level 3 – Significant inputs to the valuation model are unobservable.

IMPACT OF RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS

PRESENTATION OF AN UNRECOGNIZED TAX BENEFIT WHEN A NET OPERATING LOSS CARRYFORWARD, A SIMILAR TAX LOSS, OR A TAX CREDIT CARRYFORWARD EXISTS

In July 2013, Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2013-11 relating to income taxes (FASB ASC 740 – Income Taxes), which provides guidance on the presentation of unrecognized tax benefits. The intent is to better reflect the manner in which an entity would settle at the reporting date any additional income taxes that would result from the disallowance of a tax position when net operating loss carryforwards, similar tax losses, or tax credit carryforwards exist. This pronouncement is effective for fiscal years, and interim periods within those years, beginning after December 15, 2013. We are evaluating the impact that the adoption of this standard may have on our consolidated financial statements.

INDEFINITE-LIVED INTANGIBLE ASSETS IMPAIRMENT TESTING

In July 2012, the FASB issued ASU 2012-02, Testing Indefinite-Lived Intangible Assets for Impairment (“ASU 2012-02”), which amended the provisions of FASB ASC 350, Intangibles - Goodwill and Other. ASU 2012-02 permits an entity to make a qualitative assessment of whether it is more likely than not that an indefinite-lived intangible asset is less than its carrying amount before applying the second step of the impairment test. If an entity concludes that it is not more likely than not that the fair value of an indefinite-lived intangible asset is less than its carrying amount, it would not be required to perform the second step of the impairment test for that indefinite-lived intangible asset. The new standard is effective for annual and interim indefinite-lived intangible assets impairment tests performed in fiscal years beginning after December 15, 2012, which for us was April 1, 2013. We adopted this amended guidance in the third quarter of fiscal 2014. The adoption of this guidance did not impact our financial position or results of operations.

Note_2_Business_Acquisitions

Note 2 - Business Acquisitions	12 Months Ended
Note 2 - Business Acquisitions	Mar. 31, 2014
Business Combinations [Abstract]	'
Business Combination Disclosure [Text Block]	'
	2. BUSINESS ACQUISITIONS

	On August 27, 2010, the Company completed its acquisition of AVID, a provider of custom procedure trays to the healthcare industry, in which the Company acquired the outstanding shares of common stock of AVID for $62,550. During fiscal 2012, the Company recorded $125 in final purchase price adjustments. The purpose of this acquisition is to expand our product line offering into custom procedure trays to augment our existing product classes and expand our market presence in clinical care areas of acute care facilities and surgery centers throughout the country.

Note_3_Discontinued_Operations

Note 3 - Discontinued Operations	12 Months Ended
Note 3 - Discontinued Operations	Mar. 31, 2014
Discontinued Operations and Disposal Groups [Abstract]	'
Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]	'
	3. DISCONTINUED OPERATIONS

	On March 12, 2014, the Company entered into a purchase agreement with an affiliate of Inteplast Group, Ltd. for the sale of the Company’s wholly owned subsidiary, Medegen Medical Products, LLC, and certain other assets which comprised the Company’s Patient Care business unit (the “Transaction”). The Company retained the cash, accounts receivable and all liabilities associated with the business unit except for an environmental liability. On June 2, 2014, the Company completed the sale of its Patient Care business unit for gross proceeds of $78,628, subject to customary post-closing adjustments (see Footnote 15 – Subsequent Events).

	As of March 31, 2014, the Company has classified the assets and liabilities subject to the purchase agreement as held for sale and presented the results of operations of the Patient Care business unit for fiscal years 2014, 2013 and 2012 as discontinued operations in the accompanying consolidated statements of operations.

	The aggregate components of the assets and liabilities classified as held for sale, are as follows;

		31-Mar-14
	Asset held for sale:
	Inventories, net	$	18,369
	Property, plant and equipment, net		17,431
	Goodwill		10,877
	Other intangible assets, net		10,236
	Other assets, net		4,200
	Total assets held for sale, current	$	61,113

	Liabilities held for sale:
	Other liabilities	$	4,200
	Total liabilities held for sale, current	$	4,200

	The following table summarizes the results of the Company’s discontinued operations;

		Fiscal Year-Ended March 31,
		2014		2013		2012
	Net sales	$	145,882	$	156,830	$	164,588
	Cost of sales		125,476		135,358		143,771
	Selling, general and administrative expenses		15,584		16,122		18,185
	Income from discontinued operations before income taxes		4,822		5,350		2,632
	Income tax		1,737		2,152		989
	Income from discontinued operations, net of income taxes	$	3,085	$	3,198		1,643

Note_4_Inventories_Net

Note 4 - Inventories, Net	12 Months Ended
	Mar. 31, 2014
Inventory Disclosure [Abstract]	'
Inventory Disclosure [Text Block]	'
	4. INVENTORIES, NET

	Inventories, which are stated at the lower of cost (first-in, first-out) or market, consist of the following:

		March 31,
		2014		2013
	Finished goods, net	$	15,582	$	30,531
	Raw materials, net		10,367		17,766
	Work in progress, net		6,769		4,717
	Total, net	$	32,718	$	53,014

	At March 31, 2014, the Company reclassed $18,369 ($19,156 of inventories, less provisions for slow moving, excess and obsolete inventory of $787) to reflect the inventories that are included in the assets held for sale related to the Transaction, as disclosed in Footnote 3 – Discontinued Operations.

	On a continuing basis, inventory quantities on hand are reviewed and an analysis of the provision for slow moving, excess and obsolete inventory is performed based primarily on the Company’s sales history and anticipated future demand. Such provision for slow moving, excess and obsolete inventory approximated $953 and $1,091 at March 31, 2014 and 2013, respectively.

	In fiscal 2013 we identified an overstatement of inventories at our West Virginia location that arose during the five year period ended March 31, 2012 and the nine months ended December 31, 2012. After consideration of both quantitative and qualitative factors, we determined the amounts were not material to any of those prior period financial statements or the fiscal 2013 consolidated results of operations and thus corrected the inventory balance in the fiscal year 2013 and the three months ended March 31, 2013. The adjustment resulted in a reduction of inventory of $829, with a corresponding increase in cost of sales in the consolidated statement of operations for the fiscal year ended March 31, 2013.

Note_5_Income_Taxes

Note 5 - Income Taxes	12 Months Ended
Note 5 - Income Taxes	Mar. 31, 2014
Income Tax Disclosure [Abstract]	'
Income Tax Disclosure [Text Block]	'
	5. INCOME TAXES

	Income tax expense related to continuing operations consists of the following:

		Fiscal Year Ended March 31,
		2014			2013			2012
	Current:
	Federal	$	1,064		$	(20,627	)	$	-
	State		601			(1,124	)		-
	Deferred		(503	)		-			283
		$	1,162		$	(21,751	)	$	283

	The following table indicates the significant elements contributing to the difference between the statutory federal tax rate and the Company’s effective tax rate on income from continuing operations for fiscal years 2014, 2013, and 2012:

		Fiscal Year Ended March 31,
		2014			2013			2012
	Tax at federal statutory rate		35	%		35	%		35	%
	State taxes, net of federal benefit		17.7			1.7			(0.9	)
	Net non-deductible expenses		(0.6	)		-			(5.1	)
	Non-deductible goodwill impairment charge		-			(9.1	)		-
	Increase in valuation allowance		(0.9	)		(0.3	)		(46.4	)
	Effective tax rate		51.2	%		27.3	%		(17.4	)%

	The components of deferred tax assets and deferred tax liabilities at March 31, 2014 and 2013 are as follows:

		March 31,
		2014			2013
	Deferred tax assets:
	Stock-based compensation	$	2,553		$	2,209
	Inventory reserve		844			567
	Allowance for doubtful accounts		250			333
	Accrued expenses		440			720
	Net state operating loss carryforwards of acquired company		1,288			1,037
	Capital leases		5,483			5,396
			10,858			10,262
	Valuation allowance		(1,017	)		(1,037	)
	Total deferred tax assets	$	9,841		$	9,225

	Deferred tax liabilities:
	Goodwill	$	8,127		$	6,356
	Depreciation and amortization		6,995			7,874
	Total deferred tax liabilities	$	15,122		$	14,230
	Net deferred tax liability	$	5,281		$	5,005

	In assessing whether the deferred tax asset is realizable, management considers whether it is more likely than not that some portion or all of the deferred tax assets will be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible.

	The Company maintains a valuation allowance against certain state net operating loss carry forwards as the Company could not conclude that it will be able to utilize the state net operating loss carry forwards on a more-likely-than-not basis. During fiscal 2014, the Company decreased its valuation allowance by $20. As of March 31, 2014, the Company’s valuation allowance amounted to $1,017.

	A reconciliation of the beginning and ending amount of unrecognized tax benefits, excluding interest and penalties, is as follows:

	Balance at March 31, 2012	$	21
	Additions based on tax positions taken in the current and prior years		526
	Balance at March 31, 2013	$	547
	Additions based on tax positions taken in the current and prior years		340
	Balance at March 31, 2014	$	887

	The Company records accrued interest and penalties related to income tax matters in the provision for income taxes in the accompanying consolidated statement of operations. The accrued gross interest and penalties were $125 as of March 31, 2014 and $48 as of March 31, 2013. In addition, the Company believes that the uncertain tax positions will not materially change within the next twelve months.

	The Company is subject to taxation by the U.S. Government and various state and local jurisdictions. The Company’s U.S. federal tax return and most state jurisdictions remain open to examination for the fiscal year ended March 31, 2011 through March 31, 2014. During fiscal 2014, the Company concluded a New York State examination for the fiscal years ended March 31, 2011, 2010 and 2009 with an immaterial assessment. The Company is currently subject to income tax audits in New Jersey and Massachusetts, however, the examinations are preliminary.

Note_6_Accrued_Expenses

Note 6 - Accrued Expenses	12 Months Ended
Note 6 - Accrued Expenses	Mar. 31, 2014
Payables and Accruals [Abstract]	'
Accounts Payable and Accrued Liabilities Disclosure [Text Block]	'
	6. ACCRUED EXPENSES

	Accrued expenses consist of the following:

		March 31,
		2014		2013
	Accrued accounts payable	$	6,219	$	7,488
	Accrued bonuses		4,109		1,825
	Employee compensation and benefits		3,025		3,022
	Other accrued liabilities		2,291		1,887
	Accrued distributor fees		2,011		3,608
	Group purchasing organization fees		1,977		1,569
	Freight and duty		901		1,270
	Professional fees		767		1,178
	Commissions		624		768
	Book cash overdraft		-		2,491
	Total accrued expenses	$	21,924	$	25,106

Note_7_Leases_and_Related_Part

Note 7 - Leases and Related Party Transactions	12 Months Ended
Note 7 - Leases and Related Party Transactions	Mar. 31, 2014
Leases And Related Party Transactions Disclosure [Abstract]	'
Leases And Related Party Transactions Disclosure [Text Block]	'
	7. LEASES AND RELATED PARTY TRANSACTIONS

	As part of the assets and liabilities acquired as a result of the AVID acquisition, the Company assumed a capital lease obligation for the AVID facility located in Toano, Virginia. The facility, which includes a 185,000 square foot manufacturing and warehouse building and approximately 12 acres of land, is owned by an affiliate of Micpar Realty, LLC (“Micpar”). AVID’s founder, former CEO and former principal stockholder, is a part owner of Micpar and subsequent to the acquisition of AVID was appointed to the Company’s board of directors. As of August 2012, he no longer served on the Company’s board of directors. As of March 31, 2014, the capital lease requires monthly payments of $129 with increases of 2% per annum. The lease contains provisions for an option to buy January 2015 and expires in March 2029. The effective rate on the capital lease obligation is 9.9%.

	The gross and net book value of the assets under the capital lease are as follows:

		March 31,
		2014			2013
	Capital lease, gross	$	11,409		$	11,409
	Less: accumulated amortization		(2,200	)		(1,586	)
	Capital lease, net	$	9,209		$	9,823

	The amortization expense associated with the capital lease amounted to $614, of which $141 is included in cost of sales and the remaining $473 is recorded in selling, general and administrative expenses.

	The Company also leases certain equipment, vehicles and office facilities under non-cancelable operating leases expiring in various years though fiscal 2020.

	As of March 31, 2014, the Company was obligated under non-cancelable operating leases and capital leases for equipment, vehicles and office, warehousing and manufacturing facilities for minimum annual rental payments as follows:

	Fiscal Year	Capital Lease			Operating
	Fiscal Year	Capital Lease			Leases
	2015	$	1,549		$	1,030
	2016		1,580			791
	2017		1,611			75
	2018		1,643			63
	2019		1,676			30
	Thereafter		18,722			-
	Total minimum lease payments	$	26,781			1,989
	Less: Amounts representing interest		(13,310	)
	Present value of minimum lease payments		13,471
	Less: Current portion of capital lease obligations		(226	)
	Long-term portion of capital lease obligations	$	13,245

	Rental expense under operating leases amounted to $628, $579, and $488 during fiscal 2014, 2013, and 2012, respectively.

	A current member of our board of directors is currently a minority shareholder of Custom Healthcare Systems (“CHS”), an assembler and packager of Class 1 medical products. CHS is a supplier to our AVID facility located in Toano, Virginia for small kits and trays. They also purchase sterile instruments from our facility located in Arden, North Carolina.

	During the twelve months ended March 31, 2014 and 2013, the amounts sold to and purchased from CHS are as follows:

		March 31,
		2014			2013

	Sold to CHS	$	1,074		$	964
	Purchased from CHS		1,729			1,861

	The following table represents the amounts due from and due to CHS:

		March 31,
		2014			2013

	Due from CHS	$	330		$	265
	Due to CHS		14			45

Note_8_LongTerm_Debt

Note 8 - Long-Term Debt	12 Months Ended
	Mar. 31, 2014
Debt Disclosure [Abstract]	'
Debt Disclosure [Text Block]	'
	8. LONG-TERM DEBT

	Long-term debt consists of the following:

		March 31,
		2014		2013
	Revolving loans	$	29,976	$	4,700
	Term loan		10,136		48,000
	Total outstanding	$	40,112	$	52,700

	Less: current portion		40,112		1,370
	Total long-term debt	$	-	$	51,330

	On May 17, 2013, the Company entered into a credit agreement (the “New Credit Agreement”), among the Company, as borrower and Wells Fargo Bank, National Association, as administrative agent and lender. The New Credit Agreement provides for a maximum borrowing capacity of $65,000 consisting of the following loans: (1) a $11,505 secured term loan (the “Term Loan”) fully drawn by the Company on May 17, 2013, (2) $5,000 in unsecured delayed draw term loans (collectively, the “Delayed Draw Term Loans”) and (3) up to $53,495 in revolving loans (collectively, the “Revolving Loans”), which may be reduced by the amount of any outstanding Delayed Draw Term Loans drawn by the Company. The proceeds from the New Credit Agreement were used to repay the Prior Credit Agreement (as described below). This repayment took place on June 2, 2014 commensurate with the completion of the divestiture of the Patient Care business unit. Consequently, the entire outstanding balance has been classified as current on our balance sheet as of March 31, 2014.

	The Revolving Loans will be used to finance the working capital needs and general corporate purposes of the Company and for permitted acquisitions. The Term Loan and Revolving Loan mature on May 17, 2018. The commitments with respect to the Delayed Draw Term Loans terminate on May 17, 2015 and any Delayed Draw Term Loans drawn by the Company also mature on May 17, 2015. The Term Loan amortizes in consecutive monthly installments, each in the principal amount of $137, commencing June 1, 2013. Any Delayed Draw Term Loan drawn by the Company will amortize in consecutive monthly installments, each in the principal amount equal to the result of (1) the original principal amount of such Delayed Draw Term Loan divided by (2) the number of months remaining from the date the Delayed Draw Term Loan was drawn until May 17, 2015. Any undrawn commitments under the Delayed Draw Term Loans will be reduced by $208 on each calendar month, commencing June 1, 2013.

	In the event the outstanding principal amount of the Term Loan exceeds the sum of (1) a specified percentage of the value of real property (calculated at least twice during the term of the New Credit Agreement) and (2) a specified percentage of the value of equipment (calculated at least once per calendar year), we will be required to prepay the excess. The Revolving Loans are subject to a borrowing base such that the total outstanding Revolving Loans may not exceed specified percentages of the value of eligible receivables and finished goods, raw materials, work-in-process and in-transit inventory, all calculated at least monthly. In the event the outstanding principal amount of Revolving Loans under the New Credit Agreement exceeds this borrowing base, the Company will be required to prepay the excess.

	Term Loans outstanding under the New Credit Agreement bear interest at a rate per annum equal to, at the election of the Company, (1) LIBOR Rate (as defined in the New Credit Agreement) plus a margin ranging from 2.50% to 3.00%, depending on the Average Access Availability (as defined in the New Credit Agreement) at the time of calculation, or (2) Base Rate (as defined in the New Credit Agreement) plus a margin ranging from 1.50% to 2.00%, depending on the Average Access Availability at the time of calculation. Revolving Loans outstanding under the New Credit Agreement will bear interest at a rate per annum equal to, at the election of the Company, (i) LIBOR Rate plus a margin ranging from 2.00% to 2.50%, depending on the Average Access Availability at the time of calculation, or (ii) Base Rate plus a margin ranging from 1.00% to 1.50%, depending on the Average Access Availability at the time of calculation. Additionally, the Company is required to pay an unused line fee at a rate per annum ranging from 0.375% to 0.50% on the daily unused amount of the Revolving Loan commitments of the Lender during the period for which the payment is made, payable monthly in arrears. If drawn, Delayed Draw Term Loans outstanding under the New Credit Agreement will bear interest at a rate per annum equal to, at the election of the Company, (1) LIBOR Rate plus a margin ranging from 4.25% to 4.75%, depending on the Average Access Availability at the time of calculation, or (2) Base Rate plus a margin ranging from 3.25% to 3.75%, depending on the Average Access Availability at the time of calculation.

	During fiscal 2014, the average interest rate on the Term Loan under the New Credit Agreement approximated 2.86% and the average interest rate on the Revolving Loans under the New Credit Agreement approximated 3.22%.

	Borrowings under the New Credit Agreement are collateralized by substantially all the assets of, and are fully guaranteed by, the Company and its subsidiaries. The New Credit Agreement contains certain restrictive covenants, including, among others, covenants limiting our ability to incur indebtedness, grant liens, guarantee obligations, sell assets, make loans and investments, enter into merger and acquisition transactions, and declare or make dividends. The Company committed to certain post-closing conditions, including providing monthly financial statements, annual updates of financial projections, and the filing of a mortgage on the Company’s Brentwood, New York corporate headquarters. If the Company’s Excess Availability (as defined in the New Credit Agreement) falls below a specified amount, the Company will become subject to financial covenants relating to a minimum fixed charge coverage ratio of 1.00 to 1.00, measured on a month-end basis. If the Company draws a Delayed Draw Term Loan, the Company will be required to comply with a maximum leverage financial ratio covenant ranging from 3:00 to 1:00 to 3.25 to 1:00, measured on a month-end basis.

	On June 2, 2014, the Company entered into the First Amendment to Credit Agreement and Guaranty and Security Agreement (the “Amendment”), among the Company, as borrower, and Wells Fargo Bank, National Association, as administrative agent and lender (the “Lender”).

	The Amendment amended the terms of the New Credit Agreement that the Company entered into with the Lender on May 17, 2013, as follows: (a) the Lender’s maximum total loan commitments under the Credit Agreement were reduced from $65,000 to $55,000, (b) provided no Event of Default (as defined in the Credit Agreement) occurs and is continuing, the unused line fee (the “Unused Line Fee”) that the Company is required to pay the Lender, has been capped at 0.375% of the daily unused amount of the revolving loan commitments of the Lender during the period for which the payment is made, through and including December 31, 2014, and (c) solely for purposes of calculating the Unused Line Fee, the aggregate amount of the Lender’s revolving loan commitments was deemed to be the lesser of $30,000 and the actual aggregate amount of the Lender’s revolving loan commitments.

	As a result of the Transaction, the Company repaid all amounts outstanding on both the Revolving and Term loans under the New Credit Agreement subsequent to year end and has recorded all amounts due related to the New Credit Agreement as current as of March 31, 2014.

	The Company had unamortized financing costs of $1,068 and $879 in other assets, net as of March 31, 2014 and 2013, respectively. Of the amount at March 31, 2014, approximately $216 is related to the Term Loan and, as a result of the Transaction, will be charged to interest expense during the three months ending June 30, 2014. The remaining balance represents costs associated with the Revolving Loans and will be amortized over the remaining life of the New Credit Agreement using the straight-line interest method.

	On June 7, 2012, the Company entered into the Second Amended and Restated Credit Agreement (the “Prior Credit Agreement”) with certain lenders and JPMorgan Chase Bank, N.A. acting as administrative agent for the lenders. The Prior Credit Agreement provided the Company with total borrowings of up to $76,000, consisting of (1) a secured term loan with a principal amount of $51,000 and (2) a secured revolving credit facility, which amounts may be borrowed, repaid and re-borrowed up to $25,000. Both the term loan and the revolving credit facility bore interest at LIBOR plus 4% under the terms of the Prior Credit Agreement. The average interest rate on the term loan under the Prior Credit Agreement approximated 6.25% during the fiscal year ended March 31, 2014, and the average interest rate on the revolving credit facility under the Prior Credit Agreement approximated 4.25% during the fiscal year ended March 31, 2014.

	On May 17, 2013, a portion of the proceeds from the New Credit Agreement was used to repay all amounts owed under the Prior Credit Agreement. Upon such repayment, all obligations under the Prior Credit Agreement were satisfied and the agreement was terminated.

Note_9_Fair_Value_Measurements

Note 9 - Fair Value Measurements	12 Months Ended
Note 9 - Fair Value Measurements	Mar. 31, 2014
Fair Value Disclosures [Abstract]	'
Fair Value Disclosures [Text Block]	'
	9. FAIR VALUE MEASUREMENTS

	Due to their maturities and/or variable interest rates, certain financial instruments have fair values that approximate their carrying values. These instruments include cash and cash equivalents, accounts receivable, trade payables and our outstanding debt under the Company’s term loan and revolving credit facility. The book value and the fair value of the Company’s capital lease obligation amounted to $13,471 and $15,479, respectively as of March 31, 2014. The fair value was determined based on the Company’s current incremental borrowing rate and is considered a Level 3 input. As discussed in Note 1 – Organization and Summary of Significant Accounting Policies, Goodwill and Other Intangible Assets, Level 3 inputs were used in the fair value calculation related to the step-one impairment analysis as well as the fair value calculation of the Company’s property, plant and equipment, inventories, capital lease and other intangible assets in the step-two impairment analysis during the year ended March 31, 2013.

Note_10_Earnings_Loss_Per_Shar

Note 10 - Earnings (Loss) Per Share	12 Months Ended
Note 10 - Earnings (Loss) Per Share	Mar. 31, 2014
Earnings Per Share [Abstract]	'
Earnings Per Share [Text Block]	'
	10. EARNINGS (LOSS) PER SHARE

	The following is a reconciliation of the numerator and denominator of the basic and diluted net earnings (loss) per share computations for fiscal 2014, 2013, and 2012, respectively.

		March 31,
		2014		2013			2012
	Numerator :
	Income (loss) from continuing operations before extraordinary gain	$	1,107	$	(58,054	)	$	(1,917	)
	Income (loss) from discontinued operations, net of income taxes (Footnote 3)		3,085		3,198			1,643
	Extraordinary gain (net of tax expense) (Footnote 13)		-		-			455
	Net income (loss) for basic and dilutive earnings per share	$	4,192	$	(54,856	)	$	181


	Denominator :
	Denominator for basic earnings per share - weighted average shares		16,391		16,391			16,391

	Effect of dilutive securities:
	Employee and director stock options		75		-			-
	Denominator for diluted earnings per share - adjusted weighted average shares		16,466		16,391			16,391

	Basic earnings (loss) per share :
	Net income (loss) from continuing operations, before extraordinary gain	$	0.07	$	(3.54	)	$	(0.12	)
	Net income from discontinued operations	$	0.19	$	0.19		$	0.1
	Extraordinary gain, net of income taxes	$	-	$	-		$	0.03
	Net income (loss)	$	0.26	$	(3.35	)	$	0.01

	Diluted earnings (loss) per share :
	Net income (loss) from continuing operations, before extraordinary gain	$	0.07	$	(3.54	)	$	(0.12	)
	Net income from discontinued operations	$	0.18	$	0.19		$	0.1
	Extraordinary gain, net of income taxes	$	-	$	-		$	0.03
	Net income (loss)	$	0.25	$	(3.35	)	$	0.01

	Excluded from the calculation of diluted earnings (loss) per share are options to purchase 1,429,472 shares in fiscal, 2014, 1,407,270 shares in fiscal 2013, and 1,329,240 shares in fiscal 2012, as their inclusion would have been anti-dilutive.

Note_11_Stockholders_Equity_an

Note 11 - Stockholders' Equity and Stock Plans	12 Months Ended
Note 11 - Stockholders' Equity and Stock Plans	Mar. 31, 2014
Stockholders' Equity Note [Abstract]	'
Stockholders' Equity Note Disclosure [Text Block]	'
	11. STOCKHOLDERS’ EQUITY AND STOCK PLANS

	The Company accounts for its three stock-based compensation plans in accordance with the provisions of ASC 718, Stock Compensation. Under the provisions of ASC 718, stock-based compensation cost is measured at the grant date, based on the calculated fair value of the related award, and is recognized as an expense over the service period applicable to the grantee. The service period is the period of time that the grantee must provide services to the Company before the stock-based compensation is fully vested.

	STOCK OPTIONS

	The Company currently grants stock options under the 1989 Non-Qualified Stock Option Plan (the “Non-Qualified Option Plan”), the 1994 Stock Incentive Plan (the “Incentive Plan”) and the 1996 Non-Employee Director Stock Option Plan (the “Director Plan”). The Non-Qualified Option Plan was approved by the Company’s Board of Directors and stockholders and provides for the grant of stock options with an exercise price equal to the fair market price or at a value that is not less than 85% of the fair market value on the date of grant and are exercisable in three installments on the second, third and fourth anniversary of the date of grant. The Incentive Plan was adopted by the Company’s Board of Directors and stockholders and provides for the granting of incentive stock options, shares of restricted stock and non-qualified stock options to all officers and key employees of the Company and its affiliates at an exercise price that may not be less than the fair market value of a share of common stock at the time of grant. The Director Plan was approved by the stockholders in August 1996 and as amended, grants each non-employee director of the Company an option to purchase 7,500 shares of the Company’s common stock after each year of service. All options granted under the above plans expire from five to ten years from the date of grant unless the employment is terminated, in which event, subject to certain exceptions, the options terminate two months subsequent to date of termination.

	RESTRICTED STOCK AWARDS

	Grants of restricted stock are common stock awards granted to recipients with specified vesting provisions. The restricted stock issued vests based upon the recipients continued service over time (five-year vesting period). The Company estimates the fair value of restricted stock based on the Company’s closing stock price on the date of grant.

	The following is a summary of the changes in restricted stock granted under the Incentive Plan for the fiscal years presented:

			Fiscal Year Ended March 31,
			2014								2013							2012
			Shares				Weighted				Shares				Weighted			Shares			Weighted
							Average								Average						Average
							Price								Price						Price

	Beginning Balance			5,625			$	12.58				7,500			$	12.58			7,967		$	12.74
	Granted			-				-				-				-			-			-
	Vested			(1,875	)		$	12.58				(1,875	)		$	12.58			(467	)	$	15.31
	Cancelled			-				-				-				-			-			-
	Ending Balance			3,750			$	12.58				5,625			$	12.58			7,500		$	12.58

	VALUATION ASSUMPTIONS FOR STOCK OPTION GRANTS

	The fair value of each option grant is estimated on the date of the grant using the Black-Scholes options pricing model. Use of a valuation model requires management to make certain assumptions with respect to selected model inputs. The expected term of the options is based on evaluations of historical and expected future employee exercise behavior. The risk-free rate is based on the U.S. Treasury rates at the date of grant with maturity dates approximately equal to the life of the grant. The expected volatility is based on the historical volatility of the Company’s stock. The following table summarizes the assumptions used to determine the fair value of options granted during the following periods:

			Fiscal Year Ended March, 31
			2014				2013				2012
	Expected dividend yield			0	%			0	%			0	%
	Expected volatility			63.02	%			63.34	%			64.44	%
	Risk-free interest rate			1.04	%			1.64	%			2.36	%
	Expected life (years)			5.37				5.33				5.33
	Weighted average fair value of options granted		$	4.37			$	1.99			$	2.99

	STOCK-BASED COMPENSATION EXPENSE

	The Company recognized stock-based compensation expense (before deferred income tax benefits) for awards granted under the Company’s stock-based compensation plans in the following line items in the consolidated statements of operations for fiscal 2014, 2013, and 2012:

			2014				2013				2012

	Cost of sales		$	4			$	16			$	11
	Selling, general and administrative expenses			848				974				566
	Stock-based compensation expense before income tax benefits		$	852			$	990			$	577

	Information regarding the Company's stock option activity for fiscal 2012, 2013 and 2014 are summarized below:

			Number of				Weighted				Weighted				Aggregate
			Options				Average				Average				Intrinsic Value
							Exercise				Remaining
							Price				Contractual Life
											(years)
	Options outstanding at March 31, 2011			1,328,937			$	12.62

	Granted			30,000				5.24
	Exercised			(7,500	)			2.67
	Forfeited			(3,000	)			8.87
	Options outstanding at March 31, 2012			1,348,437			$	12.44

	Granted			327,500				3.58
Exercised			-				-
Forfeited			(196,937	)			10
Options outstanding at March 31, 2013			1,479,000			$	10.8

Granted			511,000				8
Exercised			-				-
Forfeited			(297,250	)			9.85
Options outstanding at March 31, 2014			1,692,750			$	10.12				6.2			$	982

Exercisable at March 31, 2014			945,500			$	12.18				4.3			$	346

Vested and expected to vest at March 31, 2014			1,606,829			$	10.27				6			$	928

The total fair value of shares vested during the fiscal year ended March 31, 2014 was $1,078. As of March 31, 2014, there was $3,083 of total unrecognized compensation cost related to non-vested share-based compensation arrangements granted under the Company’s plans, which is expected to be recognized over a weighted average period of 1.94 years.

Summarized information about stock options outstanding as of March 31, 2014 and 2013 is as follows:

				2014
				Outstanding												Exercisable
								Weighted				Weighted							Weighted
								Average				Average							Average
Range of Exercise				Options				Remaining				Exercise Price				Options			Exercise Price
Prices per Common								Contractual Life				Per Common							Per Common
Share								(Years)				Share							Share
$2.62	-	$10.97			1,022,500				8			$	7.38				357,750		$	8.12
$10.98	-	$19.36			573,550				3.4			$	13.06				491,050		$	13.26
$19.37	-	$23.27			96,700				3.1			$	21.72				96,700		$	21.72

$ 2.62	-	$23.27			1,692,750				6.2			$	10.12				945,500		$	12.18

				2013
				Outstanding												Exercisable
								Weighted				Weighted							Weighted
								Average				Average							Average
Range of Exercise				Options				Remaining				Exercise Price				Options			Exercise Price
Prices per Common								Contractual Life				Per Common							Per Common
Share								(Years)				Share							Share
$2.62	-	$10.97			724,250				6.9			$	7.04				328,937		$	8.57
$10.98	-	$19.36			640,550				4.5			$	13.11				495,800		$	13.46
$19.37	-	$23.27			114,200				4.2			$	21.72				114,200		$	21.72

$ 2.62	-	$23.27			1,479,000				5.6			$	10.8				938,937		$	12.75

The aggregate pre-tax intrinsic value (the difference between the Company’s closing stock price on the last trading day of fiscal 2014 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their options on March 31, 2014 was $982. This amount changes based on the fair market value of the Company’s stock. The total intrinsic value of options exercised for fiscal 2014, 2013, and 2012 to amounted to $0, $0, and $47, respectively.

The following is a summary of changes in non-vested stock options for the fiscal year ended March 31, 2014:

		Shares				Weighted
						Average Grant
						Date Fair
						Value
Non-vested shares at April 1, 2013			540,063			$	4.09
Granted			511,000				4.37
Forfeited			(90,000	)			3.11
Vested			(213,813	)			5.04
Non-vested shares at March 31, 2014			747,250			$	4.13

The options and restricted stock available for future issuance as of March 31, 2014 are shown below:

		1989 Non-				1994 Stock				1996 Non-				Total
		Qualified				Incentive Plan				Employee
		Option								Stock
		Plan								Option Plan
Authorized by Directors and Stockholders			3,975,000				3,525,000				750,000				8,250,000
Options previously exercised			(3,214,687	)			(2,025,187	)			(100,000	)			(5,339,874	)
Restricted stock previously granted			-				(93,750	)			-				(93,750	)
Options outstanding			(436,000	)			(1,051,750	)			(205,000	)			(1,692,750	)
Remaining for future issuance			324,313				354,313				445,000				1,123,626

Note_12_Retirement_Plans

Note 12 - Retirement Plans	12 Months Ended
Note 12 - Retirement Plans	Mar. 31, 2014
Compensation and Retirement Disclosure [Abstract]	'
Pension and Other Postretirement Benefits Disclosure [Text Block]	'
	12. RETIREMENT PLANS

	401(k) PLAN

	Effective January 1, 2010, the Company amended its 401(k) retirement plan to be subject to the provisions of a “Safe Harbor” 401(k) plan. Under the provisions of the Safe Harbor plan, any discretionary matching company contribution becomes 100% vested upon match. The plan provides for a discretionary match of up to 4% of an eligible employee’s compensation. Under the prior plan, adopted in April 1988, any remaining unvested company discretionary matching contributions are subject to a four year vesting schedule. The Company’s contributions under both the 1988 plan and the Safe Harbor plan amounted to $771 in fiscal 2014, $789 in fiscal 2013 and $690 in fiscal 2012.

	DEFINED BENEFIT PLAN

	The Company assumed a defined benefit pension plan (the “Plan”) with the Medegen Medical Products, LLC (“MMP”) acquisition. The Plan covers certain employees of MMP who are members of the Service Employees International Union. The benefit accruals for the Plan were frozen as of December 31, 1999. The Company’s funding policy is to make the minimum annual contributions required by applicable regulations. Such contributions are expected to amount to $125 during fiscal 2015.

	The following table sets forth the Plan’s funded status and amount recognized in the Company’s financial statements as of and for the fiscal years ended March 31, 2014 and 2013:

			2014				2013
	Change in projected benefit obligation:
	Benefit obligation at beginning of year		$	1,894			$	1,761
	Interest cost			76				78
	Actuarial (gain) loss			(34	)			111
	Benefits paid			(58	)			(56	)
	Benefit obligation at end of year			1,878				1,894
	Change in plan assets:
	Fair value of plan assets at beginning of year		$	1,143			$	1,029
	Actual return on plan assets			58				66
	Employer contributions			80				104
	Benefits paid			(58	)			(56	)
	Fair value of plan assets at end of year		$	1,223			$	1,143
	Funded status at end of the year		$	(655	)		$	(751	)
	Amounts recognized on the balance sheet consist of:
	Current liabilities		$	(655	)		$	(751	)
	Accumulated other comprehensive loss			651				773
	Net amount recognized		$	(4	)		$	22

	The following table presents the major categories of assets held by the plan, measured at fair value, as of March 31, 2014.

			Fair Value Measurements at Reporting Date Using
			Level 1				Level 2				Level 3			Total
	Cash and cash equivalents		$	-			$	24			$	-		$	24
	Debt securities			-				432				-			432
	Equity securities			-				767				-			767
	Totals		$	-			$	1,223			$	-		$	1,223

	The following table presents the major categories of assets held by the plan, measured at fair value, as of March 31, 2013.

			Fair Value Measurements at Reporting Date Using
			Level 1				Level 2				Level 3			Total
	Cash and cash equivalents		$	23			$	-			$	-		$	23
	Debt securities			402				-				-			402
	Equity securities			-				718				-			718
	Totals		$	425			$	718			$	-		$	1,143

	The net periodic pension cost for the years ended March 31, 2014, 2013 and 2012 were as follows:

			2014				2013				2012
	Service cost - benefits earned during the period		$	-			$	-			$	-
	Interest cost on projected benefit obligation			76				78				81
	Expected investment income			(70	)			(64	)			(59	)
	Net amortization and deferral			64				53				26
	Net periodic pension cost		$	70			$	67			$	48

	The following are weighted-average assumptions used to determine benefit obligations as of March 31, 2014 and 2013:

			2014				2013
	Discount rate			4.25	%			4.07	%
	Rate of compensation increase			0	%			0	%

The following are weighted-average assumptions used to determine net periodic benefit costs for the years ended March 31, 2014 and 2013:

		2014				2013
Discount rate			4.07	%			4.49	%
Expected long-term return on plan assets			6	%			6	%
Rate of compensation increase			0	%			0	%

The Company’s investment policy for the Plan’s assets is to balance risk and return through a diversified portfolio of marketable securities, including common and preferred stocks, convertible securities, government, municipal and corporate bonds, mutual and collective investment funds and short-term money market instruments. Maturities for fixed income securities are managed so that sufficient liquidity exists to meet near-term benefit-payment obligations. The expected rate of return on plan assets is based upon expectations of long-term average rates of return to be achieved by the underlying investment portfolios. In establishing this assumption, the Company considers historical and expected rates of return for the asset classes in which the Plan’s assets are invested, as well as current economic and capital market conditions.

Weighted-average asset allocation by asset category as of March 31, 2014 and 2013 were as follows:

		Target Range				2014				2013
Cash		0%	-	20%			2	%			2	%
Debt securities		10%	-	70%			63	%			63	%
Equity securities		30%	-	90%			35	%			35	%
Total							100	%			100	%

Benefits paid were $58 and $56 for fiscal 2014 and 2013, respectively. The Company estimates the following future benefit payments under the plan for the fiscal years ending March 31:

	Fiscal Year		Amount
	2015		$	60
	2016			67
	2017			71
	2018			74
	2019			77
	2020 - 2023			527
			$	876

Note_13_Extraordinary_Items

Note 13 - Extraordinary Items	12 Months Ended
Note 13 - Extraordinary Items	Mar. 31, 2014
Extraordinary and Unusual Items [Abstract]	'
Extraordinary Items Disclosure [Text Block]	'
	13. EXTRAORDINARY ITEMS

	During fiscal 2012, the Company recorded an extraordinary gain of $455 (net of tax expense of $245) as a result of an insurance settlement relating to inventories damaged in fiscal 2011 as a result of weather−related water damage.

Note_14_Other_Matters

Note 14 - Other Matters	12 Months Ended
Note 14 - Other Matters	Mar. 31, 2014
Commitments and Contingencies Disclosure [Abstract]	'
Commitments and Contingencies Disclosure [Text Block]	'
	14. OTHER MATTERS

	The Company is a party to a lawsuit arising out of the conduct of its ordinary course of business. A global settlement of claims has been approved by the court and management expects a settlement agreement to be executed by the plaintiffs. While execution of the settlement agreement by the plaintiffs cannot be predicted with certainty, the ultimate liability under such lawsuit is covered by the Company’s insurance and management does not expect that the court-approved amount of the settlement or any other ultimate liability, if any, arising out of such lawsuit, will have a material adverse effect on the financial position or results of operations of the Company.

	The Company has entered into agreements with seven of its executive officers and a vice president, which provide certain benefits in the event of a change in control of the Company. A “change in control” of the Company is defined as, in general, the acquisition by any person of beneficial ownership of 20% or more of the voting stock of the Company, certain business combinations involving the Company or a change in a majority of the incumbent members of the Board of Directors, except for changes in the majority of such members approved by such members. If, within two years after a change in control, the Company or, in certain circumstances, the executive, terminates his employment, the executive is entitled to a severance payment equal to 2.99 times (1) such executive’s highest annual salary within the five-year period preceding termination plus (2) a bonus increment equal to the average of the two highest of the last five bonuses paid to such executive. In addition, the executive is entitled to the continuation of all employment benefits for a three-year period, the vesting of all stock options and certain other benefits. As of March 31, 2014, the estimated potential aggregate compensation payable to these seven executive officers and vice president under the Company’s compensation and benefit plans and arrangements in the event of termination of such executive’s employment following a change in control amounted to approximately $12,556.


	The Company’s Tennessee facility, which is comprised of approximately 25 acres in a light industrial park located in Gallaway, Tennessee, was acquired by Medegen Medical Products, LLC in 1999 prior to the Company’s ownership of Medegen. In connection with an environmental due diligence evaluation of the facility prior to its acquisition by Medegen, consultants detected the presence of chlorinated solvents in groundwater beneath the manufacturing plant. The identified groundwater contamination is in the process of being remediated. At the time of our acquisition of Medegen, the prior owner of the facility agreed to retain responsibility for the remediation of the contamination and to fully indemnify our company for all costs associated with the environmental remediation as well as any claims that might arise, including third party claims. Under an agreement executed at the time of the sale, Vollrath Group, Inc. and its parent Windway Capital Corp. (collectively, “Indemnitor”) are required, on a quarterly basis, to provide documentation from independent parties confirming that Indemnitor has sufficient assets, in the form of unencumbered, unrestricted cash, marketable securities or unused and available borrowing capacity, as necessary to pay the most recently estimated costs of outstanding environmental remediation obligations. Now that full-scale remediation is underway at the site, Indemnitor is also required to provide Letters of Credit (“LC”) to secure its current and future obligations, including a $2,000 LC that is currently open and future LCs in the amount of $1,000 from December 7, 2014 through December 7, 2017. As of March 31, 2014, we have recorded an estimated liability of $4,200 to remediate the groundwater contamination and corresponding amount due from the Indemnitor. As part of the divestiture of the Patient Care business unit, the related asset and liabilities are reported as held for sale at March 31, 2014 (see Footnote 3 – Discontinued Operations).

Note_15_Subsequent_Events

Note 15 - Subsequent Events	12 Months Ended
Note 15 - Subsequent Events	Mar. 31, 2014
Subsequent Events [Abstract]	'
Subsequent Events [Text Block]	'
	15. SUBSEQUENT EVENTS

	Sale of Medegen Medical Products, LLC

	On June 2, 2014, the Company completed the sale to Medira Inc., a Delaware corporation and an affiliate of Inteplast Group, Ltd., of (i) 100% of the membership units of Medegen Medical Products, LLC, a Delaware limited liability company and a wholly-owned indirect subsidiary of the Company, and (ii) certain assets of the Company’s Patient Care business unit, including the containment business assets, collectively, for approximately $78,628 in cash, subject to customary post-closing adjustments.

	The Company used approximately $40,000 of the net proceeds from the Transaction to repay the term loan and outstanding revolving loan obligations under the New Credit Agreement. The Company plans to use the remaining balance of approximately $38,628 for working capital to support future growth in the Company’s business.

	Amended Credit Agreement

	On June 2, 2014, the Company entered into the First Amendment to Credit Agreement and Guaranty and Security Agreement (the “Amendment”), among the Company, as borrower, and Wells Fargo Bank, National Association, as administrative agent and lender (the “Lender”).

	The Amendment amended the terms of the New Credit Agreement that the Company entered into with the Lender on May 17, 2013, as follows: (a) the Lender’s maximum total loan commitments under the Credit Agreement were reduced from $65,000 to $55,000, (b) provided no Event of Default (as defined in the Credit Agreement) occurs and is continuing, the unused line fee (the “Unused Line Fee”) that the Company is required to pay the Lender, has been capped at 0.375% of the daily unused amount of the revolving loan commitments of the Lender during the period for which the payment is made, through and including December 31, 2014, and (c) solely for purposes of calculating the Unused Line Fee, the aggregate amount of the Lender’s revolving loan commitments was deemed to be the lesser of $30,000 and the actual aggregate amount of the Lender’s revolving loan commitments.

Note_16_Summary_of_Unaudited_Q

Note 16 - Summary of Unaudited Quarterly Financial Data	12 Months Ended
Note 16 - Summary of Unaudited Quarterly Financial Data	Mar. 31, 2014
Quarterly Financial Information Disclosure [Abstract]	'
Quarterly Financial Information [Text Block]	'
	16. SUMMARY OF UNAUDITED QUARTERLY FINANCIAL DATA

	Selected unaudited, quarterly financial data of the Company for the fiscal years ended March 31, 2014 and 2013 appear below.

		Fiscal 2014 Quarter Ended
		30-Jun			30-Sep			31-Dec			31-Mar

	Net sales	$	71,526		$	71,320		$	72,521		$	72,482
	Gross profit		13,384			13,271			13,896			14,465
	Income after income taxes
	Continuing operations		90			205			305			507
	Discontinued operations		189			893			1,606			397
	Net income	$	279		$	1,098		$	1,911		$	904

	Basic earnings per common share:
	Net income from continuing operations	$	0.01		$	0.02		$	0.02		$	0.03
	Net income from discontinued operations	$	0.01		$	0.05		$	0.1		$	0.03
	Total	$	0.02		$	0.07		$	0.12		$	0.06

	Diluted earnings per common share:
	Net income from continuing operations	$	0.01		$	0.02		$	0.02		$	0.03
	Net income from discontinued operations	$	0.01		$	0.05		$	0.1		$	0.02
	Total	$	0.02		$	0.07		$	0.12		$	0.05

		Fiscal 2013 Quarter Ended
		30-Jun			30-Sep			31-Dec			31-Mar

	Net sales	$	70,177		$	72,393		$	72,824		$	69,369
	Gross profit		12,214			12,366			13,558			12,759
	Income (loss) after income taxes
	Continuing operations		(387	)		(507	)		(56,536	)		(624	)
	Discontinued operations		250			572			1,033			1,343
	Net income (loss)	$	(137	)	$	65		$	(55,503	)	$	719

	Basic earnings per common share:
	Net income (loss) from continuing operations	$	(0.03	)	$	(0.03	)	$	(3.45	)	$	(0.04	)
	Net income from discontinued operations	$	0.02		$	0.03		$	0.06		$	0.08
	Total	$	(0.01	)	$	-		$	(3.39	)	$	0.04

	Diluted earnings per common share:
	Net income (loss) from continuing operations	$	(0.03	)	$	(0.03	)	$	(3.45	)	$	(0.04	)
	Net income from discontinued operations	$	0.02		$	0.03		$	0.06		$	0.08
	Total	$	(0.01	)	$	-		$	(3.39	)	$	0.04

	Net income (loss) per common share is computed separately for each quarter. Therefore, the sum of such quarterly per share amounts may differ from the total for the years.

Schedule_II_Valuation_and_Qual

Schedule II - Valuation and Qualifying Accounts	12 Months Ended
Schedule II - Valuation and Qualifying Accounts	Mar. 31, 2014
Valuation and Qualifying Accounts [Abstract]	'
Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]	'
	Description	Balance at		Gross			Charged to			Other			Balance at
		Beginning		Amount			Other			Charges/			End of Year
		of Year		Charged to			Accounts			(Deductions)
				Cost and
				Expenses
	Year Ended March 31, 2014
	Allowance for doubtful accounts	$	793	$	(292	)	$	-		$	-		$	501
	Reserve for slowing moving, excess and obsolete inventory		1,091		1,011			(786	)(c)		(363	)(b)		953
	Valuation allowance on deferred tax assets		1,037		(20	)		-			-			1,017
		$	2,921	$	699		$	(786	)	$	(363	)	$	2,471

	Year Ended March 31, 2013
	Allowance for doubtful accounts	$	781	$	12		$	-		$	-		$	793
	Reserve for slowing moving, excess and obsolete inventory		1,015		540			-			(464	)(b)		1,091
	Valuation allowance on deferred tax assets		758		279			-			-			1,037
		$	2,554	$	831		$	-		$	(464	)	$	2,921

	Year Ended March 31, 2012
	Allowance for doubtful accounts	$	804	$	72		$	-		$	(95	)(a)	$	781
	Reserve for slowing moving, excess and obsolete inventory		1,415		252			-			(652	)(b)		1,015
	Valuation allowance on deferred tax assets		-		758			-			-			758
		$	2,219	$	1,082		$	-		$	(747	)	$	2,554

	(a) Write off of uncollected accounts

	(b) Disposal of slow moving and obsolete inventory

	(c) Represents amounts related to assets held for sale

Accounting_Policies_by_Policy_

Accounting Policies, by Policy (Policies)

12 Months Ended

Mar. 31, 2014

Accounting Policies [Abstract]

Nature of Operations [Text Block]

COMPANY BACKGROUND AND DESCRIPTION OF BUSINESS

Medical Action Industries Inc. (“Medical Action” or the “Company”) was incorporated under the laws of the State of New York on April 1, 1977, and re-incorporated under the laws of the State of Delaware on November 5, 1987. Headquartered in Brentwood, New York, Medical Action develops, manufactures, markets and supplies a variety of disposable medical products. The Company’s products are marketed primarily to acute care facilities throughout the United States and certain international markets, and in recent years the Company has expanded its end-user markets to include physician, dental and veterinary offices, outpatient surgery centers and long-term care facilities. Medical Action is a leading manufacturer and supplier of custom procedure trays, collection systems for the containment of medical waste, minor procedure kits and trays, disposable patient utensils, sterile operating room towels and sterile laparotomy sponges. The Company’s products are marketed by its direct sales personnel and an extensive network of health care distributors. Medical Action has entered into preferred vendor agreements with national and regional distributors, as well as sole and multi-source agreements with group purchasing organizations. The Company also offers original equipment manufacturer products under private label programs to supply chain partners and medical suppliers. Medical Action’s manufacturing, packaging and warehousing activities are conducted in its Arden, North Carolina and Toano, Virginia facilities. The Company’s procurement of certain products and raw materials from the People’s Republic of China is administered by its office in Shanghai, China. During fiscal 2014, we also conducted manufacturing, packaging and warehousing activities at our Clarksburg, West Virginia and Gallaway, Tennessee facilities. These facilities were part of the assets sold in the Patient Care business unit divestiture completed on June 2, 2014 (the "Transaction"), as disclosed in Footnote 3 – Discontinued Operations.

All dollar amounts presented in the notes to consolidated financial statements are presented in thousands, except share and per share data.

Segment Reporting, Policy [Policy Text Block]

BUSINESS SEGMENTS AND OTHER FINANCIAL INFORMATION

We operate as one reportable segment which is the manufacture and supply of disposable medical products. During the fiscal years ended 2014, 2013 and 2012 international sales approximated 2% of our total net sales and the net book value of our long-lived assets held outside of the United States were immaterial at March 31, 2014 and 2013.

Consolidation, Policy [Policy Text Block]

PRINCIPLES OF CONSOLIDATION

The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.

Use of Estimates, Policy [Policy Text Block]

USE OF ESTIMATES

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, such as valuation of inventories, allowance for doubtful accounts, valuation of deferred tax assets, goodwill and other intangible assets, provision for trade rebates, pension benefits and accrued expenses, at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Cash and Cash Equivalents, Policy [Policy Text Block]

CASH EQUIVALENTS

The Company considers all highly liquid investments with an original maturity of 90 days or less to be cash equivalents.

Receivables, Policy [Policy Text Block]

ACCOUNTS RECEIVABLE, ALLOWANCE FOR DOUBTFUL ACCOUNTS AND CONCENTRATION OF CREDIT RISK

Accounts receivable are comprised principally of trade accounts receivable that arise primarily from the sale of goods on account and are stated at historical cost. The Company performs ongoing credit evaluations on its customers and adjusts credit limits based upon payment history and the customer’s current credit worthiness, as determined by a review of their current credit information. The Company continuously monitors collections and payments from customers and a provision for estimated credit losses is maintained based upon its historical experience and on specific customer collection issues that have been identified. While such credit losses have historically been within the Company’s expectations and the provisions established, the Company cannot guarantee that the same credit loss rates will be experienced in the future. Concentration risk exists relative to the Company’s accounts receivable, net, as Owens & Minor, Inc. and Cardinal Health Inc., (the “Distributors”) accounted for approximately 60% and 64% of accounts receivable, respectively as of March 31, 2014 and 2013. While the accounts receivable related to these Distributors may be significant, the Company does not believe the credit risk to be significant given their consistent payment history.

Trade Rebate [Policy Text Block]

TRADE REBATES

The Company provides rebates to distributors that sell to end-user customers at prices determined under a contract between the Company and the end-user customer or distributor. The Company deducts all rebates from sales and has a provision for allowances based on historical information for all rebates that have not yet been processed. The provision for trade rebates (which is included in accounts receivable) amounted to $14,331 and $14,807 at March 31, 2014 and 2013, respectively.

Inventory, Policy [Policy Text Block]

INVENTORIES, NET

Inventories are stated at the lower of cost or market net of reserve for excess, slow moving and obsolete inventory. Cost is determined by the first-in, first-out method.

Property, Plant and Equipment, Policy [Policy Text Block]

PROPERTY, PLANT AND EQUIPMENT, NET

Property, plant and equipment are stated at cost less accumulated depreciation and amortization. Leases meeting the criteria for capitalization are recorded at the present value of future minimum lease payments. Maintenance and repairs are charged to operations as incurred and expenditures for major improvements are capitalized. The carrying amount and related accumulated depreciation of assets sold or otherwise disposed of are removed from the accounts and any resulting gain or loss is reflected in operations in the year of disposal. Accelerated methods of depreciation are used for tax purposes.

A summary of property, plant and equipment, net, is as follows:

March 31,

2014

2013

Land and buildings

19,079

29,751

Property under capital lease

11,409

Machinery and equipment

8,520

36,326

Furniture and fixtures

3,161

3,351

Computer hardware and software

1,546

2,192

Total property, plant and equipment

43,715

83,029

Less accumulated depreciation and amortization

17,554

38,069

Property, plant and equipment, net

26,161

44,960

At March 31, 2014, the Company reclassed $17,431 ($41,629 of gross carrying amount, less accumulated depreciation of $24,198) to reflect the property, plant and equipment that are included in the assets held for sale related to the Transaction, as disclosed in Footnote 3 – Discontinued Operations.

Depreciation is calculated on the straight-line method over the estimated useful lives of the assets as follows:

Buildings (years)

Machinery and equipment (years)

Furniture and fixtures (years)

Computer hardware and software (years)

Leasehold improvements are depreciated over the shorter of the estimated useful life or the term of the lease.

Depreciation and amortization of property, plant and equipment amounted to $2,042, $2,259, and $2,890, for fiscal 2014, 2013, and 2012, respectively.

Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]

GOODWILL AND OTHER INTANGIBLE ASSETS

Goodwill and other intangible assets consist of the excess of the purchase price over the fair value of net assets acquired (goodwill) and other intangible assets (principally customer relationships, trademarks and tradenames). Values assigned to the respective assets are determined in accordance with ASC 805, Business Combinations and ASC 350, Intangibles – Goodwill and Other.

Goodwill and intangible assets with indefinite useful lives are required to be tested for impairment at least annually or more frequently if an event occurs or circumstances change that could more likely than not reduce the fair value of a reporting unit below its carrying amount. Intangible assets with estimable useful lives are required to be amortized over their respective estimated useful lives and reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable.

The Company conducts its goodwill and intangible assets with indefinite lives as of December 31 of each year. The Company assesses the impairment of its goodwill by determining its fair value and comparing the fair value to its carrying value. For goodwill impairment testing purposes, the Company has determined that it operates under one reporting unit.

The Company’s annual step one impairment testing as of December 31, 2012 indicated that the fair value of the Company was estimated to be less than its related carrying value. The fair value of the Company was estimated using a discounted cash flow and guideline company model. As a result of the step one testing, management determined that the goodwill balance of the Company was impaired and step two testing was necessary.

Step two of the goodwill test consists of performing a hypothetical purchase price allocation, under which the estimated fair value of the Company is allocated to its tangible and intangible assets based on their estimated fair values, with any residual amount being assigned to goodwill. During the step two analysis, it was determined that book value approximated fair value for the components of working capital except for finished goods and work-in-process inventory which was determined based on estimated selling prices less distribution costs and profit and costs to complete manufacture. Owned real estate and buildings were valued using recently completed real estate appraisals. Other property, plant and equipment items were valued using current market value estimates. The intangible assets related to customer relationships were valued using a present value of debt-free cash flow model and the trade names were valued using the relief-from-royalty model.

The models used to determine the fair value of the Company in step one and the intangible assets in step two relied heavily on management’s assumptions. These assumptions, which are significant to the calculated fair values, are considered Level 3 inputs under the fair value hierarchy established by ASC 820 – Fair value measurement and disclosures , as they are unobservable. The assumptions in step one included a discount rate, revenue growth rates, tax rates and operating margins. In addition, the step two assumptions included customer attrition rates and royalty rates. The discount rate represents the expected return on capital. The discount rate was determined using a target structure of 15% debt and 85% equity. The Company used the 20-year U.S. Treasury bond yield to determine the risk-free rate in its weighted average cost of capital calculation. The projected growth rates and terminal growth rates are primarily driven by management’s estimate of future performance, giving consideration to historical performance and existing and anticipated economic and market conditions. Attrition assumptions used to value customer relationships are based on historical experience and management estimates based on historical financial information. To determine the royalty rates used to value trade names, the Company used industry benchmarks from licensing transactions. The assumption for tax rates are based on management’s estimates of blended federal and state income tax rates. Operating margin assumptions are based management’s estimate of future performance, giving consideration to historical performance and projected economic and competitive conditions.

During fiscal 2013 the preliminary impairment analysis conducted at December 31, 2012 concluded that $78,609 of goodwill was impaired, which was recorded in the Company’s condensed consolidated statement of operations for the nine months ended December 31, 2012. Due to the complexity of the analysis which involved completion of fair value analyses and the resolution of certain significant assumptions, management finalized this goodwill impairment charge in the fourth quarter of fiscal 2013 by reducing the initial goodwill impairment charge by $829 to $77,780. Previous and subsequent analyses of goodwill did not indicate an impairment, therefore the amounts of impairment incurred during the fiscal year ended March 31, 2013 represent the cumulative amount of goodwill impairment charges as of March 31, 2014.

Changes in the carrying amount of goodwill were as follows:

Balance, March 31, 2012

107,801

Goodwill impairment charge

(77,780

)

Balance, March 31, 2013

30,021

Amounts reclassified to assets held-for-sale

(10,877

)

Balance, March 31, 2014

19,144

The book values, accumulated amortization and original useful life by asset class of the Company’s other intangible assets as of March 31, 2014 and 2013 are as follows:

31-Mar-14

31-Mar-13

Weighted

Gross

Accumulated

Net

Gross

Accumulated

Net

Average

Carrying

Amortization

Carrying

Amortization

Carrying

Remaining

Amount

Amortization

Period

(Years)

Trademarks/Tradenames not subject to amortization

569

1,266

Trademarks subject to amortization (5 years)

1.4

2,100

(1,505

)

595

2,100

(1,085

)

1,015

Customer Relationships (20 years)

16.4

27,500

(4,927

)

22,573

43,200

(8,927

)

34,273

Intellectual Property (7 Years)

400

(368

)

Total

30,169

(6,432

)

23,737

46,966

(10,380

)

36,586

At March 31, 2014, the Company reclassed $10,236 ($18,997 of gross carrying amount, less accumulated amortization of $8,761) to reflect the customer relationships and other intangible assets that are included in the assets held for sale related to the Transaction, as disclosed in Footnote 3 – Discontinued Operations.

The amortization expense for other intangible assets amounted to $1,795, $1,795, and $1,795 for fiscal 2014, 2013, and 2012, respectively. Estimated amortization expense related to these intangibles for the five succeeding fiscal years is as follows:

Fiscal Year

Amount

2015

1,795

2016

1,550

2017

1,375

2018

1,375

2019

1,375

The Company evaluates trademarks with indefinite lives annually to determine whether events or circumstances continue to support the indefinite useful life. No impairments of such assets were identified in fiscal 2014, 2013, and 2012. No trademarks were determined to have finite useful lives in any of the periods presented, with the exception of the trademarks acquired in the AVID acquisition, which have a useful life of 5 years.

Accounts Payable [Policy Text Block]

ACCOUNTS PAYABLE

Cash overdrafts are included in accounts payable. Such cash book overdrafts amounted to $5,690 and $5,372 at March 31, 2014 and 2013, respectively. For cash flow disclosure purposes, the Company reports the cash book overdrafts as an operating activity as opposed to a financing activity.

Deferred Charges, Policy [Policy Text Block]

DEFERRED FINANCING COSTS

The Company has incurred costs in obtaining financing. These costs of approximately $1,068 as of March 31, 2014 are included in other assets and are being amortized over the life of the related financing arrangements through fiscal 2019. Total accumulated amortization was approximately $240 and $882 at March 31, 2014 and 2013, respectively. In connection with the Company’s debt refinancing in May 2013 (see Footnote 8 – Long-Term Debt), the net balance of deferred financing costs associated with the Company’s prior debt was charged to operations during the twelve months ending March 31, 2014.

Income Tax, Policy [Policy Text Block]

INCOME TAXES

We account for income taxes under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities from a change in tax rates is recognized in income in the period that includes the enactment date.

We must also assess the likelihood that deferred tax assets will be realized and, based on this assessment establish a valuation allowance, if required. The determination of our valuation allowance involves assumptions, judgments, and estimates, including forecasted earnings, future taxable income, and the relative proportions of revenue and income before taxes in the various state and local jurisdictions in which we operate. To the extent we establish a valuation allowance or change the valuation allowance in a period, we reflect the change with a corresponding increase or decrease to our tax provision in our consolidated statement of operations.

We are also required to compute our current income tax expense in each federal, state, and local jurisdiction in which we operate. Our judgments, assumptions, and estimates relative to the current provision for income tax take into account current tax laws, our interpretation of current tax laws, and possible outcomes of current and future audits. Changes in tax laws or our interpretation of tax laws and the resolution of current and future tax audits could significantly impact the amounts provided for income taxes in our consolidated balance sheet and consolidated statement of operations.

In accordance with the provisions of ASC 740, Income Taxes, we recognize in our financial statements only those tax positions that meet the more-likely-than-not-recognition threshold. For those tax positions where it is more-likely-than-not that a tax benefit will be sustained, we have recorded the largest amount of tax benefit with a greater than 50% likelihood of being realized upon settlement. For those tax positions where it is not more-likely-than-not that a tax benefit will be sustained, no tax benefit has been recognized in the consolidated financial statements. Interest and penalties associated with income tax matters are included in the provision for income taxes in our consolidated statements of operations. The provisions of ASC 740 did not have a material impact on our consolidated financial position.

Basis Of Currency Used [Policy Text Block]

CURRENCY

All of the Company’s sales and purchases were transacted in U.S. dollars.

Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]

STOCK-BASED COMPENSATION

The Company recorded stock-based compensation expense for the fair value of non-qualified stock options and restricted stock granted under its stock plans in accordance with the provisions of ASC 718, Stock Compensation

Earnings Per Share, Policy [Policy Text Block]

EARNINGS (LOSS) PER SHARE INFORMATION

Basic earnings (loss) per share is based on the weighted average number of common shares outstanding without consideration of potential common stock. Diluted earnings (loss) per share is based on the weighted average number of common and potential common shares outstanding. The calculation takes into account the shares that may be issued upon exercise of stock options and restricted stock, reduced by the shares that may be repurchased with the funds received from the exercise, based on average prices during the year.

Revenue Recognition, Policy [Policy Text Block]

REVENUE RECOGNITION

Revenue from the sale of products is recognized when the Company meets all of the criteria specified in ASC 605, Revenue Recognition. These criteria include:

• Persuasive evidence of an arrangement exists,

• Delivery has occurred or services have been rendered,

• The seller’s price to the buyer is fixed or determinable and

• Collection of the resulting receivable is reasonably assured.

Customer purchase orders and/or sales agreements evidence the Company’s sales arrangements. These purchase orders and sales agreements specify both selling prices and quantities, which are the basis for recording sales revenue. Any deviation from this policy requires management review and approval. Trade terms are negotiated on a customer by customer basis and for the majority of the Company’s sales include that title and risk of loss pass from the Company to the customer when the Company ships products from its facilities, which is when revenue is recognized. In instances of shipments made on consignment, revenue is deferred until a customer indicates to the Company that it has used the Company’s products. The Company conducts ongoing credit evaluations of its customers and ships products only to customers that satisfy its credit evaluations. Products are shipped primarily to distributors at an agreed upon list price. Distributors then resell the products primarily to hospitals and depending on agreements between the Company, the distributors and the hospitals, the distributors may be entitled to a rebate. The Company deducts all rebates from sales and has a provision for allowances based on historical information for all rebates that have not yet been processed

Concentration Risk, Credit Risk, Policy [Policy Text Block]

BUSINESS CONCENTRATIONS AND MAJOR CUSTOMERS

The Company manufactures and distributes disposable medical products principally to medical product distributors and hospitals located throughout the United States. The Company performs credit evaluations of its customers’ financial condition and does not require collateral. Receivables are generally due within 30 – 90 days. Credit losses relating to customers have historically been minimal and within management’s expectations.

Sales to Owens & Minor, Inc. and Cardinal Health Inc., (the “Distributors”) accounted for approximately 45% and 19% of net sales, respectively for fiscal 2014, 41% and 22% of net sales, respectively for fiscal 2013 and 44% and 22% of net sales, respectively for fiscal 2012. Although the Distributors may be deemed in a technical sense to be major purchasers of the Company’s products, they typically serve as a distributor between the end user and the Company and do not make significant purchases for their own account. The Company, therefore, does not believe it is appropriate to include the Distributors when evaluating customer concentrations.

A significant portion of the Company’s raw materials are purchased from China. All such purchases are transacted in U.S. dollars. The Company’s financial results, therefore, could be impacted by factors such as foreign currency exchange rates or weak economic conditions in foreign countries in the procurement of such raw materials should our suppliers increase prices to account for changes in foreign exchange rates.

Shipping and Handling Cost, Policy [Policy Text Block]

FREIGHT AND DISTRIBUTION COSTS

Freight costs, which consist primarily of freight costs paid to third party carriers amounted to $6,323, $6,521 and $9,324 for fiscal 2014, 2013 and 2012, respectively, and are included in cost of sales. Distribution costs, which consist primarily of the salaries, warehousing and related expenses associated with the storing, packing and shipping costs of our products amounted to $3,249, $2,931 and $2,422 for fiscal 2014, 2013, and 2012, respectively, and are included in selling, general and administrative expenses.

Research and Development Expense, Policy [Policy Text Block]

PRODUCT DEVELOPMENT COSTS

Product development costs which are expensed as incurred were $1,171, $1,862, and $1,921 for fiscal 2014, 2013, and 2012, respectively, and are included as a component of selling, general and administrative expenses.

Advertising Costs, Policy [Policy Text Block]

ADVERTISING COSTS

Advertising costs charged to expense, as incurred, were $6, $41, and $20, for fiscal 2014, 2013 and 2012, respectively.

Fair Value Measurement, Policy [Policy Text Block]

FAIR VALUE MEASUREMENTS

We are required to record certain assets and liabilities at fair value and to make disclosures about the fair value of certain other assets and liabilities. Fair value is the price the Company would receive to sell an asset or pay to transfer a liability in an orderly transaction with a market participant at the measurement date. In the absence of active markets for identical assets or liabilities, such measurements involve developing assumptions based on market observable data and, in the absence of such data, internal information that is consistent with what market participants would use in a hypothetical transaction that occurs at the measurement date.

Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect our market assumptions. Preference is given to observable inputs. These two types of inputs create the following fair value hierarchy:

Level 1 – Quoted prices for identical instruments in active markets.

Level 2 – Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable.

Level 3 – Significant inputs to the valuation model are unobservable.

New Accounting Pronouncements, Policy [Policy Text Block]

IMPACT OF RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS

PRESENTATION OF AN UNRECOGNIZED TAX BENEFIT WHEN A NET OPERATING LOSS CARRYFORWARD, A SIMILAR TAX LOSS, OR A TAX CREDIT CARRYFORWARD EXISTS

In July 2013, Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2013-11 relating to income taxes (FASB ASC 740 – Income Taxes), which provides guidance on the presentation of unrecognized tax benefits. The intent is to better reflect the manner in which an entity would settle at the reporting date any additional income taxes that would result from the disallowance of a tax position when net operating loss carryforwards, similar tax losses, or tax credit carryforwards exist. This pronouncement is effective for fiscal years, and interim periods within those years, beginning after December 15, 2013. We are evaluating the impact that the adoption of this standard may have on our consolidated financial statements.

INDEFINITE-LIVED INTANGIBLE ASSETS IMPAIRMENT TESTING

In July 2012, the FASB issued ASU 2012-02, Testing Indefinite-Lived Intangible Assets for Impairment (“ASU 2012-02”), which amended the provisions of FASB ASC 350, Intangibles - Goodwill and Other. ASU 2012-02 permits an entity to make a qualitative assessment of whether it is more likely than not that an indefinite-lived intangible asset is less than its carrying amount before applying the second step of the impairment test. If an entity concludes that it is not more likely than not that the fair value of an indefinite-lived intangible asset is less than its carrying amount, it would not be required to perform the second step of the impairment test for that indefinite-lived intangible asset. The new standard is effective for annual and interim indefinite-lived intangible assets impairment tests performed in fiscal years beginning after December 15, 2012, which for us was April 1, 2013. We adopted this amended guidance in the third quarter of fiscal 2014. The adoption of this guidance did not impact our financial position or results of operations.

Note_1_Organization_and_Summar1

Note 1 - Organization and Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Mar. 31, 2014
Accounting Policies [Abstract]	'
Property, Plant and Equipment [Table Text Block]	'
			March 31,
			2014			2013

	Land and buildings		$	19,079		$	29,751
	Property under capital lease			11,409			11,409
	Machinery and equipment			8,520			36,326
	Furniture and fixtures			3,161			3,351
	Computer hardware and software			1,546			2,192
	Total property, plant and equipment			43,715			83,029
	Less accumulated depreciation and amortization			17,554			38,069
	Property, plant and equipment, net		$	26,161		$	44,960
Schedule of Goodwill [Table Text Block]	'
	Balance, March 31, 2012		$	107,801
	Goodwill impairment charge			(77,780	)
	Balance, March 31, 2013		$	30,021
	Amounts reclassified to assets held-for-sale			(10,877	)
	Balance, March 31, 2014		$	19,144
Schedule of Finite-Lived Intangible Assets [Table Text Block]	'
						31-Mar-14							31-Mar-13
			Weighted			Gross		Accumulated			Net		Gross		Accumulated			Net
			Average			Carrying		Amortization			Carrying		Carrying		Amortization			Carrying
			Remaining			Amount					Amount		Amount					Amount
			Amortization
			Period
			(Years)
	Trademarks/Tradenames not subject to amortization			na		$	569	$	-		$	569	$	1,266	$	-		$	1,266
	Trademarks subject to amortization (5 years)			1.4			2,100		(1,505	)		595		2,100		(1,085	)		1,015
	Customer Relationships (20 years)			16.4			27,500		(4,927	)		22,573		43,200		(8,927	)		34,273
	Intellectual Property (7 Years)			na			-		-			-		400		(368	)		32
	Total					$	30,169	$	(6,432	)	$	23,737	$	46,966	$	(10,380	)	$	36,586
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]	'
		Fiscal Year		Amount
		2015		$	1,795
		2016			1,550
		2017			1,375
		2018			1,375
		2019			1,375

Note_3_Discontinued_Operations1

Note 3 - Discontinued Operations (Tables)	12 Months Ended
Note 3 - Discontinued Operations (Tables)	Mar. 31, 2014
Discontinued Operations and Disposal Groups [Abstract]	'
Schedule of Assets and Liabilities Classified as Held for Sale [Table Text Block]	'
		31-Mar-14
	Asset held for sale:
	Inventories, net	$	18,369
	Property, plant and equipment, net		17,431
	Goodwill		10,877
	Other intangible assets, net		10,236
	Other assets, net		4,200
	Total assets held for sale, current	$	61,113

	Liabilities held for sale:
	Other liabilities	$	4,200
	Total liabilities held for sale, current	$	4,200
Schedule of Disposal Groups, Including Discontinued Operations, Income Statement, Balance Sheet and Additional Disclosures [Table Text Block]	'
		Fiscal Year-Ended March 31,
		2014		2013		2012
	Net sales	$	145,882	$	156,830	$	164,588
	Cost of sales		125,476		135,358		143,771
	Selling, general and administrative expenses		15,584		16,122		18,185
	Income from discontinued operations before income taxes		4,822		5,350		2,632
	Income tax		1,737		2,152		989
	Income from discontinued operations, net of income taxes	$	3,085	$	3,198		1,643

Note_4_Inventories_Net_Tables

Note 4 - Inventories, Net (Tables)	12 Months Ended
Note 4 - Inventories, Net (Tables)	Mar. 31, 2014
Inventory Disclosure [Abstract]	'
Schedule of Inventory, Current [Table Text Block]	'
		March 31,
		2014		2013
	Finished goods, net	$	15,582	$	30,531
	Raw materials, net		10,367		17,766
	Work in progress, net		6,769		4,717
	Total, net	$	32,718	$	53,014

Note_5_Income_Taxes_Tables

Note 5 - Income Taxes (Tables)	12 Months Ended
Note 5 - Income Taxes (Tables)	Mar. 31, 2014
Income Tax Disclosure [Abstract]	'
Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]	'
		Fiscal Year Ended March 31,
		2014			2013			2012
	Current:
	Federal	$	1,064		$	(20,627	)	$	-
	State		601			(1,124	)		-
	Deferred		(503	)		-			283
		$	1,162		$	(21,751	)	$	283
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]	'
		Fiscal Year Ended March 31,
		2014			2013			2012
	Tax at federal statutory rate		35	%		35	%		35	%
	State taxes, net of federal benefit		17.7			1.7			(0.9	)
	Net non-deductible expenses		(0.6	)		-			(5.1	)
	Non-deductible goodwill impairment charge		-			(9.1	)		-
	Increase in valuation allowance		(0.9	)		(0.3	)		(46.4	)
	Effective tax rate		51.2	%		27.3	%		(17.4	)%
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]	'
		March 31,
		2014			2013
	Deferred tax assets:
	Stock-based compensation	$	2,553		$	2,209
	Inventory reserve		844			567
	Allowance for doubtful accounts		250			333
	Accrued expenses		440			720
	Net state operating loss carryforwards of acquired company		1,288			1,037
	Capital leases		5,483			5,396
			10,858			10,262
	Valuation allowance		(1,017	)		(1,037	)
	Total deferred tax assets	$	9,841		$	9,225

	Deferred tax liabilities:
	Goodwill	$	8,127		$	6,356
	Depreciation and amortization		6,995			7,874
	Total deferred tax liabilities	$	15,122		$	14,230
	Net deferred tax liability	$	5,281		$	5,005
Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]	'
	Balance at March 31, 2012	$	21
	Additions based on tax positions taken in the current and prior years		526
	Balance at March 31, 2013	$	547
	Additions based on tax positions taken in the current and prior years		340
	Balance at March 31, 2014	$	887

Note_6_Accrued_Expenses_Tables

Note 6 - Accrued Expenses (Tables)	12 Months Ended
Note 6 - Accrued Expenses (Tables)	Mar. 31, 2014
Payables and Accruals [Abstract]	'
Schedule of Accrued Liabilities [Table Text Block]	'
		March 31,
		2014		2013
	Accrued accounts payable	$	6,219	$	7,488
	Accrued bonuses		4,109		1,825
	Employee compensation and benefits		3,025		3,022
	Other accrued liabilities		2,291		1,887
	Accrued distributor fees		2,011		3,608
	Group purchasing organization fees		1,977		1,569
	Freight and duty		901		1,270
	Professional fees		767		1,178
	Commissions		624		768
	Book cash overdraft		-		2,491
	Total accrued expenses	$	21,924	$	25,106

Note_7_Leases_and_Related_Part1

Note 7 - Leases and Related Party Transactions (Tables)	12 Months Ended
Note 7 - Leases and Related Party Transactions (Tables)	Mar. 31, 2014
Leases And Related Party Transactions Disclosure [Abstract]	'
Schedule of Capital Leased Assets [Table Text Block]	'
		March 31,
		2014			2013
	Capital lease, gross	$	11,409		$	11,409
	Less: accumulated amortization		(2,200	)		(1,586	)
	Capital lease, net	$	9,209		$	9,823
Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]	'
	Fiscal Year	Capital Lease			Operating
	Fiscal Year	Capital Lease			Leases
	2015	$	1,549		$	1,030
	2016		1,580			791
	2017		1,611			75
	2018		1,643			63
	2019		1,676			30
	Thereafter		18,722			-
	Total minimum lease payments	$	26,781			1,989
	Less: Amounts representing interest		(13,310	)
	Present value of minimum lease payments		13,471
	Less: Current portion of capital lease obligations		(226	)
	Long-term portion of capital lease obligations	$	13,245
Schedule of Related Party Transactions [Table Text Block]	'
		March 31,
		2014			2013

	Sold to CHS	$	1,074		$	964
	Purchased from CHS		1,729			1,861
		March 31,
		2014			2013

	Due from CHS	$	330		$	265
	Due to CHS		14			45

Note_8_LongTerm_Debt_Tables

Note 8 - Long-Term Debt (Tables)	12 Months Ended
Note 8 - Long-Term Debt (Tables)	Mar. 31, 2014
Debt Disclosure [Abstract]	'
Schedule of Long-term Debt Instruments [Table Text Block]	'
		March 31,
		2014		2013
	Revolving loans	$	29,976	$	4,700
	Term loan		10,136		48,000
	Total outstanding	$	40,112	$	52,700

	Less: current portion		40,112		1,370
	Total long-term debt	$	-	$	51,330

Note_10_Earnings_Loss_Per_Shar1

Note 10 - Earnings (Loss) Per Share (Tables)	12 Months Ended
Note 10 - Earnings (Loss) Per Share (Tables)	Mar. 31, 2014
Earnings Per Share [Abstract]	'
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	'
		March 31,
		2014		2013			2012
	Numerator :
	Income (loss) from continuing operations before extraordinary gain	$	1,107	$	(58,054	)	$	(1,917	)
	Income (loss) from discontinued operations, net of income taxes (Footnote 3)		3,085		3,198			1,643
	Extraordinary gain (net of tax expense) (Footnote 13)		-		-			455
	Net income (loss) for basic and dilutive earnings per share	$	4,192	$	(54,856	)	$	181


	Denominator :
	Denominator for basic earnings per share - weighted average shares		16,391		16,391			16,391

	Effect of dilutive securities:
	Employee and director stock options		75		-			-
	Denominator for diluted earnings per share - adjusted weighted average shares		16,466		16,391			16,391

	Basic earnings (loss) per share :
	Net income (loss) from continuing operations, before extraordinary gain	$	0.07	$	(3.54	)	$	(0.12	)
	Net income from discontinued operations	$	0.19	$	0.19		$	0.1
	Extraordinary gain, net of income taxes	$	-	$	-		$	0.03
	Net income (loss)	$	0.26	$	(3.35	)	$	0.01

	Diluted earnings (loss) per share :
	Net income (loss) from continuing operations, before extraordinary gain	$	0.07	$	(3.54	)	$	(0.12	)
	Net income from discontinued operations	$	0.18	$	0.19		$	0.1
	Extraordinary gain, net of income taxes	$	-	$	-		$	0.03
	Net income (loss)	$	0.25	$	(3.35	)	$	0.01

Note_11_Stockholders_Equity_an1

Note 11 - Stockholders' Equity and Stock Plans (Tables)	12 Months Ended
Note 11 - Stockholders' Equity and Stock Plans (Tables)	Mar. 31, 2014
Stockholders' Equity Note [Abstract]	'
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity [Table Text Block]	'
			Fiscal Year Ended March 31,
			2014								2013								2012
			Shares				Weighted				Shares				Weighted				Shares				Weighted
							Average								Average								Average
							Price								Price								Price

	Beginning Balance			5,625			$	12.58				7,500			$	12.58				7,967			$	12.74
	Granted			-				-				-				-				-				-
	Vested			(1,875	)		$	12.58				(1,875	)		$	12.58				(467	)		$	15.31
	Cancelled			-				-				-				-				-				-
	Ending Balance			3,750			$	12.58				5,625			$	12.58				7,500			$	12.58
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	'
			Fiscal Year Ended March, 31
			2014				2013				2012
	Expected dividend yield			0	%			0	%			0	%
	Expected volatility			63.02	%			63.34	%			64.44	%
	Risk-free interest rate			1.04	%			1.64	%			2.36	%
	Expected life (years)			5.37				5.33				5.33
	Weighted average fair value of options granted		$	4.37			$	1.99			$	2.99
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]	'
			2014				2013				2012

	Cost of sales		$	4			$	16			$	11
	Selling, general and administrative expenses			848				974				566
	Stock-based compensation expense before income tax benefits		$	852			$	990			$	577
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]	'
			Number of				Weighted				Weighted				Aggregate
			Options				Average				Average				Intrinsic Value
							Exercise				Remaining
							Price				Contractual Life
											(years)
	Options outstanding at March 31, 2011			1,328,937			$	12.62

	Granted			30,000				5.24
	Exercised			(7,500	)			2.67
	Forfeited			(3,000	)			8.87
	Options outstanding at March 31, 2012			1,348,437			$	12.44

	Granted			327,500				3.58
	Exercised			-				-
	Forfeited			(196,937	)			10
	Options outstanding at March 31, 2013			1,479,000			$	10.8

	Granted			511,000				8
	Exercised			-				-
	Forfeited			(297,250	)			9.85
	Options outstanding at March 31, 2014			1,692,750			$	10.12				6.2			$	982

	Exercisable at March 31, 2014			945,500			$	12.18				4.3			$	346

	Vested and expected to vest at March 31, 2014			1,606,829			$	10.27				6			$	928
Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]	'
					2014
					Outstanding												Exercisable
									Weighted				Weighted								Weighted
									Average				Average								Average
	Range of Exercise				Options				Remaining				Exercise Price				Options				Exercise Price
	Prices per Common								Contractual Life				Per Common								Per Common
	Share								(Years)				Share								Share
	$2.62	-	$10.97			1,022,500				8			$	7.38				357,750			$	8.12
	$10.98	-	$19.36			573,550				3.4			$	13.06				491,050			$	13.26
	$19.37	-	$23.27			96,700				3.1			$	21.72				96,700			$	21.72

	$ 2.62	-	$23.27			1,692,750				6.2			$	10.12				945,500			$	12.18
					2013
					Outstanding												Exercisable
									Weighted				Weighted								Weighted
									Average				Average								Average
	Range of Exercise				Options				Remaining				Exercise Price				Options				Exercise Price
	Prices per Common								Contractual Life				Per Common								Per Common
	Share								(Years)				Share								Share
	$2.62	-	$10.97			724,250				6.9			$	7.04				328,937			$	8.57
	$10.98	-	$19.36			640,550				4.5			$	13.11				495,800			$	13.46
	$19.37	-	$23.27			114,200				4.2			$	21.72				114,200			$	21.72

	$ 2.62	-	$23.27			1,479,000				5.6			$	10.8				938,937			$	12.75
Schedule of Nonvested Share Activity [Table Text Block]	'
			Shares				Weighted
							Average Grant
							Date Fair
							Value
	Non-vested shares at April 1, 2013			540,063			$	4.09
	Granted			511,000				4.37
	Forfeited			(90,000	)			3.11
	Vested			(213,813	)			5.04
	Non-vested shares at March 31, 2014			747,250			$	4.13
Employee Stock Ownership Plan (ESOP) Disclosures [Table Text Block]	'
			1989 Non-				1994 Stock				1996 Non-				Total
			Qualified				Incentive Plan				Employee
			Option								Stock
			Plan								Option Plan
	Authorized by Directors and Stockholders			3,975,000				3,525,000				750,000				8,250,000
	Options previously exercised			(3,214,687	)			(2,025,187	)			(100,000	)			(5,339,874	)
	Restricted stock previously granted			-				(93,750	)			-				(93,750	)
	Options outstanding			(436,000	)			(1,051,750	)			(205,000	)			(1,692,750	)
	Remaining for future issuance			324,313				354,313				445,000				1,123,626

Note_12_Retirement_Plans_Table

Note 12 - Retirement Plans (Tables)	12 Months Ended
Note 12 - Retirement Plans (Tables)	Mar. 31, 2014
Note 12 - Retirement Plans (Tables) [Line Items]	'
Schedule of Net Funded Status [Table Text Block]	'
			2014			2013
	Change in projected benefit obligation:
	Benefit obligation at beginning of year		$	1,894		$	1,761
	Interest cost			76			78
	Actuarial (gain) loss			(34	)		111
	Benefits paid			(58	)		(56	)
	Benefit obligation at end of year			1,878			1,894
	Change in plan assets:
	Fair value of plan assets at beginning of year		$	1,143		$	1,029
	Actual return on plan assets			58			66
	Employer contributions			80			104
	Benefits paid			(58	)		(56	)
	Fair value of plan assets at end of year		$	1,223		$	1,143
	Funded status at end of the year		$	(655	)	$	(751	)
	Amounts recognized on the balance sheet consist of:
	Current liabilities		$	(655	)	$	(751	)
	Accumulated other comprehensive loss			651			773
	Net amount recognized		$	(4	)	$	22
Schedule of Changes in Fair Value of Plan Assets [Table Text Block]	'
			Fair Value Measurements at Reporting Date Using
			Level 1			Level 2			Level 3			Total
	Cash and cash equivalents		$	-		$	24		$	-		$	24
	Debt securities			-			432			-			432
	Equity securities			-			767			-			767
	Totals		$	-		$	1,223		$	-		$	1,223
			Fair Value Measurements at Reporting Date Using
			Level 1			Level 2			Level 3			Total
	Cash and cash equivalents		$	23		$	-		$	-		$	23
	Debt securities			402			-			-			402
	Equity securities			-			718			-			718
	Totals		$	425		$	718		$	-		$	1,143
Schedule of Net Benefit Costs [Table Text Block]	'
			2014			2013			2012
	Service cost - benefits earned during the period		$	-		$	-		$	-
	Interest cost on projected benefit obligation			76			78			81
	Expected investment income			(70	)		(64	)		(59	)
	Net amortization and deferral			64			53			26
	Net periodic pension cost		$	70		$	67		$	48
Schedule of Allocation of Plan Assets [Table Text Block]	'
			Target Range			2014			2013
	Cash		0%	-	20%		2	%		2	%
	Debt securities		10%	-	70%		63	%		63	%
	Equity securities		30%	-	90%		35	%		35	%
	Total						100	%		100	%
Schedule of Expected Benefit Payments [Table Text Block]	'
		Fiscal Year		Amount
		2015		$	60
		2016			67
		2017			71
		2018			74
		2019			77
		2020 - 2023			527
				$	876
Benefit Obligation [Member]	'
Note 12 - Retirement Plans (Tables) [Line Items]	'
Schedule of Assumptions Used [Table Text Block]	'
			2014			2013
	Discount rate			4.25	%		4.07	%
	Rate of compensation increase			0	%		0	%
Net Periodic Benefit Cost [Member]	'
Note 12 - Retirement Plans (Tables) [Line Items]	'
Schedule of Assumptions Used [Table Text Block]	'
			2014			2013
	Discount rate			4.07	%		4.49	%
	Expected long-term return on plan assets			6	%		6	%
	Rate of compensation increase			0	%		0	%

Note_16_Summary_of_Unaudited_Q1

Note 16 - Summary of Unaudited Quarterly Financial Data (Tables)	12 Months Ended
	Mar. 31, 2014
Quarterly Financial Information Disclosure [Abstract]	'
Schedule of Quarterly Financial Information [Table Text Block]	'
		Fiscal 2014 Quarter Ended
		30-Jun			30-Sep			31-Dec			31-Mar

	Net sales	$	71,526		$	71,320		$	72,521		$	72,482
	Gross profit		13,384			13,271			13,896			14,465
	Income after income taxes
	Continuing operations		90			205			305			507
	Discontinued operations		189			893			1,606			397
	Net income	$	279		$	1,098		$	1,911		$	904

	Basic earnings per common share:
	Net income from continuing operations	$	0.01		$	0.02		$	0.02		$	0.03
	Net income from discontinued operations	$	0.01		$	0.05		$	0.1		$	0.03
	Total	$	0.02		$	0.07		$	0.12		$	0.06

	Diluted earnings per common share:
	Net income from continuing operations	$	0.01		$	0.02		$	0.02		$	0.03
	Net income from discontinued operations	$	0.01		$	0.05		$	0.1		$	0.02
	Total	$	0.02		$	0.07		$	0.12		$	0.05
		Fiscal 2013 Quarter Ended
		30-Jun			30-Sep			31-Dec			31-Mar

	Net sales	$	70,177		$	72,393		$	72,824		$	69,369
	Gross profit		12,214			12,366			13,558			12,759
	Income (loss) after income taxes
	Continuing operations		(387	)		(507	)		(56,536	)		(624	)
	Discontinued operations		250			572			1,033			1,343
	Net income (loss)	$	(137	)	$	65		$	(55,503	)	$	719

	Basic earnings per common share:
	Net income (loss) from continuing operations	$	(0.03	)	$	(0.03	)	$	(3.45	)	$	(0.04	)
	Net income from discontinued operations	$	0.02		$	0.03		$	0.06		$	0.08
	Total	$	(0.01	)	$	-		$	(3.39	)	$	0.04

	Diluted earnings per common share:
	Net income (loss) from continuing operations	$	(0.03	)	$	(0.03	)	$	(3.45	)	$	(0.04	)
	Net income from discontinued operations	$	0.02		$	0.03		$	0.06		$	0.08
	Total	$	(0.01	)	$	-		$	(3.39	)	$	0.04

Note_1_Organization_and_Summar2

Note 1 - Organization and Summary of Significant Accounting Policies (Details) (USD $)	3 Months Ended	9 Months Ended	12 Months Ended
	Mar. 31, 2014	Dec. 31, 2013	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2012
Note 1 - Organization and Summary of Significant Accounting Policies (Details) [Line Items]	'	'	'	'	'
Property, Plant and Equipment, Gross	$43,715,000	'	$43,715,000	$83,029,000	'
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	17,554,000	'	17,554,000	38,069,000	'
Depreciation, Depletion and Amortization	'	'	2,042,000	2,259,000	2,890,000
Number of Reportable Segments	'	'	1	'	'
US Treasury Bond Maturity Period	'	'	'20 years	'	'
Goodwill, Impairment Loss	'	78,609,000	77,780,000	77,780,000	'
Goodwill, Impairment Loss Reduction	829,000	'	'	'	'
Finite-Lived Intangible Assets, Accumulated Amortization	-6,432,000	'	-6,432,000	-10,380,000	'
Amortization of Intangible Assets	'	'	1,795,000	1,795,000	1,795,000
Bank Overdrafts	5,690,000	'	5,690,000	5,372,000	'
Deferred Finance Costs, Net	1,068,000	'	1,068,000	879,000	'
Accumulated Amortization, Deferred Finance Costs	240,000	'	240,000	882,000	'
Income Tax Expense Benefit Percent Outcome	'	'	50.00%	'	'
Freight Costs	'	'	6,323,000	6,521,000	9,324,000
Shipping, Handling and Transportation Costs	'	'	3,249,000	2,931,000	2,422,000
Research and Development Expense	'	'	1,171,000	1,862,000	1,921,000
Advertising Expense	'	'	6,000	41,000	20,000
Distributors [Member] \| Customer Concentration Risk [Member] \| Accounts Receivable [Member]	'	'	'	'	'
Note 1 - Organization and Summary of Significant Accounting Policies (Details) [Line Items]	'	'	'	'	'
Concentration Risk, Percentage	'	'	60.00%	64.00%	'
Owens & Minor, Inc. [Member] \| Customer Concentration Risk [Member] \| Sales Revenue, Net [Member]	'	'	'	'	'
Note 1 - Organization and Summary of Significant Accounting Policies (Details) [Line Items]	'	'	'	'	'
Concentration Risk, Percentage	'	'	45.00%	41.00%	44.00%
Cardinal Health Inc. [Member] \| Customer Concentration Risk [Member] \| Sales Revenue, Net [Member]	'	'	'	'	'
Note 1 - Organization and Summary of Significant Accounting Policies (Details) [Line Items]	'	'	'	'	'
Concentration Risk, Percentage	'	'	19.00%	22.00%	22.00%
Trademarks [Member]	'	'	'	'	'
Note 1 - Organization and Summary of Significant Accounting Policies (Details) [Line Items]	'	'	'	'	'
Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)	'	'	0	0	0
Building [Member]	'	'	'	'	'
Note 1 - Organization and Summary of Significant Accounting Policies (Details) [Line Items]	'	'	'	'	'
Property, Plant and Equipment, Useful Life	'	'	'40 years	'	'
Machinery and Equipment [Member]	'	'	'	'	'
Note 1 - Organization and Summary of Significant Accounting Policies (Details) [Line Items]	'	'	'	'	'
Property, Plant and Equipment, Gross	8,520,000	'	8,520,000	36,326,000	'
Machinery and Equipment [Member] \| Minimum [Member]	'	'	'	'	'
Note 1 - Organization and Summary of Significant Accounting Policies (Details) [Line Items]	'	'	'	'	'
Property, Plant and Equipment, Useful Life	'	'	'5 years	'	'
Machinery and Equipment [Member] \| Maximum [Member]	'	'	'	'	'
Note 1 - Organization and Summary of Significant Accounting Policies (Details) [Line Items]	'	'	'	'	'
Property, Plant and Equipment, Useful Life	'	'	'20 years	'	'
Furniture and Fixtures [Member]	'	'	'	'	'
Note 1 - Organization and Summary of Significant Accounting Policies (Details) [Line Items]	'	'	'	'	'
Property, Plant and Equipment, Gross	3,161,000	'	3,161,000	3,351,000	'
Furniture and Fixtures [Member] \| Minimum [Member]	'	'	'	'	'
Note 1 - Organization and Summary of Significant Accounting Policies (Details) [Line Items]	'	'	'	'	'
Property, Plant and Equipment, Useful Life	'	'	'3 years	'	'
Furniture and Fixtures [Member] \| Maximum [Member]	'	'	'	'	'
Note 1 - Organization and Summary of Significant Accounting Policies (Details) [Line Items]	'	'	'	'	'
Property, Plant and Equipment, Useful Life	'	'	'10 years	'	'
Computer Hardware And Software [Member]	'	'	'	'	'
Note 1 - Organization and Summary of Significant Accounting Policies (Details) [Line Items]	'	'	'	'	'
Property, Plant and Equipment, Gross	1,546,000	'	1,546,000	2,192,000	'
Computer Hardware And Software [Member] \| Minimum [Member]	'	'	'	'	'
Note 1 - Organization and Summary of Significant Accounting Policies (Details) [Line Items]	'	'	'	'	'
Property, Plant and Equipment, Useful Life	'	'	'2 years	'	'
Computer Hardware And Software [Member] \| Maximum [Member]	'	'	'	'	'
Note 1 - Organization and Summary of Significant Accounting Policies (Details) [Line Items]	'	'	'	'	'
Property, Plant and Equipment, Useful Life	'	'	'7 years	'	'
Patient Care Divestiture [Member]	'	'	'	'	'
Note 1 - Organization and Summary of Significant Accounting Policies (Details) [Line Items]	'	'	'	'	'
Disposal Group, Including Discontinued Operation, Property, Plant, and Equipment, Net	17,431,000	'	17,431,000	'	'
Property, Plant and Equipment, Gross	41,629,000	'	41,629,000	'	'
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	24,198,000	'	24,198,000	'	'
Disposal Group, Including Discontinued Operation, Intangible Assets, Net	10,236,000	'	10,236,000	'	'
Finite-Lived Intangible Assets, Gross	18,997,000	'	18,997,000	'	'
Finite-Lived Intangible Assets, Accumulated Amortization	8,761,000	'	8,761,000	'	'
Accounts Receivable [Member]	'	'	'	'	'
Note 1 - Organization and Summary of Significant Accounting Policies (Details) [Line Items]	'	'	'	'	'
Provision For Trade Rebates	$14,331,000	'	$14,331,000	$14,807,000	'
Geographic Concentration Risk [Member] \| International [Member] \| Sales Revenue, Net [Member]	'	'	'	'	'
Note 1 - Organization and Summary of Significant Accounting Policies (Details) [Line Items]	'	'	'	'	'
Concentration Risk, Percentage	'	'	2.00%	2.00%	2.00%
AVID [Member]	'	'	'	'	'
Note 1 - Organization and Summary of Significant Accounting Policies (Details) [Line Items]	'	'	'	'	'
Finite-Lived Intangible Asset, Useful Life	'	'	'5 years	'	'
Minimum [Member]	'	'	'	'	'
Note 1 - Organization and Summary of Significant Accounting Policies (Details) [Line Items]	'	'	'	'	'
Receivables Period Due	'	'	'30 days	'	'
Maximum [Member]	'	'	'	'	'
Note 1 - Organization and Summary of Significant Accounting Policies (Details) [Line Items]	'	'	'	'	'
Receivables Period Due	'	'	'90 days	'	'
Target Structure Debt [Member]	'	'	'	'	'
Note 1 - Organization and Summary of Significant Accounting Policies (Details) [Line Items]	'	'	'	'	'
Weighted Average Discount Rate, Percent	'	'	15.00%	'	'
Target Structure Equity [Member]	'	'	'	'	'
Note 1 - Organization and Summary of Significant Accounting Policies (Details) [Line Items]	'	'	'	'	'
Weighted Average Discount Rate, Percent	'	'	85.00%	'	'

Note_1_Organization_and_Summar3

Note 1 - Organization and Summary of Significant Accounting Policies (Details) - Property, Plant and Equipment, Net (USD $)	Mar. 31, 2014	Mar. 31, 2013
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Property, Plant and Equipment [Line Items]	'	'
Fixed assets	$43,715	$83,029
Less accumulated depreciation and amortization	17,554	38,069
Property, plant and equipment, net	26,161	44,960
Land and Building [Member]	'	'
Property, Plant and Equipment [Line Items]	'	'
Fixed assets	19,079	29,751
Property Under Capital Lease [Member]	'	'
Property, Plant and Equipment [Line Items]	'	'
Fixed assets	11,409	11,409
Machinery and Equipment [Member]	'	'
Property, Plant and Equipment [Line Items]	'	'
Fixed assets	8,520	36,326
Furniture and Fixtures [Member]	'	'
Property, Plant and Equipment [Line Items]	'	'
Fixed assets	3,161	3,351
Computer Hardware And Software [Member]	'	'
Property, Plant and Equipment [Line Items]	'	'
Fixed assets	$1,546	$2,192

Note_1_Organization_and_Summar4

Note 1 - Organization and Summary of Significant Accounting Policies (Details) - Change in Goodwill (USD $)	9 Months Ended	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Mar. 31, 2014	Mar. 31, 2013
Change in Goodwill [Abstract]	'	'	'
Balance, March 31, 2012	$30,021	$30,021	$107,801
Ending Balance	'	19,144	30,021
Goodwill impairment charge	-78,609	-77,780	-77,780
Amounts reclassified to assets held-for-sale	'	($10,877)	'

Note_1_Organization_and_Summar5

Note 1 - Organization and Summary of Significant Accounting Policies (Details) - Other Intangible Assets (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Finite-Lived Intangible Assets [Line Items]	'	'
Accumulated Amortization, Intangibles Subject To Amortization	($6,432)	($10,380)
Total	30,169	46,966
Total	-6,432	-10,380
Total	23,737	36,586
Trademarks/Tradenames not subject to amortization [Member]	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Trademarks/Tradenames not subject to amortization	569	1,266
Trademarks/Tradenames not subject to amortization	569	1,266
Trademarks/Tradenames not subject to amortization	'	'
Weighted Average Remaining Amortization Period (Years)	'	'
Trademarks subject to amortization (5 years) [Member]	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Trademarks/Tradenames not subject to amortization	'1 year 146 days	'
Gross Carrying Value, Intangibles Subject To Amortization	2,100	2,100
Accumulated Amortization, Intangibles Subject To Amortization	-1,505	-1,085
Total Net Book Value, Intangibles Subject To Amortization	595	1,015
Weighted Average Remaining Amortization Period (Years)	'1 year 146 days	'
Total	-1,505	-1,085
Customer Relationships (20 years) [Member]	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Trademarks/Tradenames not subject to amortization	'16 years 146 days	'
Gross Carrying Value, Intangibles Subject To Amortization	27,500	43,200
Accumulated Amortization, Intangibles Subject To Amortization	-4,927	-8,927
Total Net Book Value, Intangibles Subject To Amortization	22,573	34,273
Weighted Average Remaining Amortization Period (Years)	'16 years 146 days	'
Total	-4,927	-8,927
Intellectual Property (7 years) [Member]	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Trademarks/Tradenames not subject to amortization	'	'
Gross Carrying Value, Intangibles Subject To Amortization	'	400
Accumulated Amortization, Intangibles Subject To Amortization	'	-368
Total Net Book Value, Intangibles Subject To Amortization	'	32
Weighted Average Remaining Amortization Period (Years)	'	'
Total	'	($368)

Note_1_Organization_and_Summar6

Note 1 - Organization and Summary of Significant Accounting Policies (Details) - Estimated Amortization Expense of Other Intangible Assets (Other Intangible Assets [Member], USD $)	Mar. 31, 2014
In Thousands, unless otherwise specified	Mar. 31, 2014
Other Intangible Assets [Member]	'
Note 1 - Organization and Summary of Significant Accounting Policies (Details) - Estimated Amortization Expense of Other Intangible Assets [Line Items]	'
2015	$1,795
2016	1,550
2017	1,375
2018	1,375
2019	$1,375

Note_2_Business_Acquisitions_D

Note 2 - Business Acquisitions (Details) (USD $)	0 Months Ended	12 Months Ended
In Thousands, unless otherwise specified	Aug. 27, 2010	Mar. 31, 2012
Business Combinations [Abstract]	'	'
Business Combination, Consideration Transferred	$62,550	'
Business Combination, Acquisition Related Costs	'	$125

Note_3_Discontinued_Operations2

Note 3 - Discontinued Operations (Details) (Subsequent Event [Member], Medegen Medical Products [Member], USD $)	0 Months Ended	1 Months Ended
In Thousands, unless otherwise specified	Jun. 02, 2014	Jun. 30, 2014
Subsequent Event [Member] \| Medegen Medical Products [Member]	'	'
Note 3 - Discontinued Operations (Details) [Line Items]	'	'
Proceeds from Divestiture of Businesses	$78,628	$78,628

Note_3_Discontinued_Operations3

Note 3 - Discontinued Operations (Details) - Aggregate Components of Assets and Liabilities Classified as Held for Sale (USD $)	Mar. 31, 2014
In Thousands, unless otherwise specified	Mar. 31, 2014
Asset held for sale:	'
Inventories, net	$18,369
Property, plant and equipment, net	17,431
Goodwill	10,877
Other intangible assets, net	10,236
Other assets, net	4,200
Total assets held for sale, current	61,113
Liabilities held for sale:	'
Other liabilities	4,200
Total liabilities held for sale, current	$4,200

Note_3_Discontinued_Operations4

Note 3 - Discontinued Operations (Details) - Results of Discontinued Operations (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2012
Results of Discontinued Operations [Abstract]	'	'	'
Net sales	$145,882	$156,830	$164,588
Cost of sales	125,476	135,358	143,771
Selling, general and administrative expenses	15,584	16,122	18,185
Income from discontinued operations before income taxes	4,822	5,350	2,632
Income tax	1,737	2,152	989
Income from discontinued operations, net of income taxes	$3,085	$3,198	$1,643

Note_4_Inventories_Net_Details

Note 4 - Inventories, Net (Details) (USD $)	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014	Mar. 31, 2013
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013	Patient Care Divestiture [Member]	Overstatement Related With Prior Years [Member]
Note 4 - Inventories, Net (Details) [Line Items]	'	'	'	'
Disposal Group, Including Discontinued Operation, Inventory	'	'	$18,369	'
Inventory, Gross	'	'	19,156	'
Inventory Valuation Reserves	953	1,091	787	'
Inventory Write-down	'	'	'	$829

Note_4_Inventories_Net_Details1

Note 4 - Inventories, Net (Details) - Inventory, Stated At Lower of Cost (First-In, First-Out) or Market (USD $)	Mar. 31, 2014	Mar. 31, 2013
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Inventory, Stated At Lower of Cost (First-In, First-Out) or Market [Abstract]	'	'
Finished goods, net	$15,582	$30,531
Raw materials, net	10,367	17,766
Work in progress, net	6,769	4,717
Total, net	$32,718	$53,014

Note_5_Income_Taxes_Details

Note 5 - Income Taxes (Details) (USD $)	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014	Mar. 31, 2014	Mar. 31, 2014
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013	State and Local Jurisdiction [Member]	Minimum [Member]	Maximum [Member]
Note 5 - Income Taxes (Details) [Line Items]	'	'	'	'	'
Valuation Allowance, Deferred Tax Asset, Change in Amount	'	'	$20	'	'
Deferred Tax Assets, Valuation Allowance	1,017	1,037	'	'	'
Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued	$125	$48	'	'	'
Open Tax Year	'	'	'	'2011	'2014

Note_5_Income_Taxes_Details_In

Note 5 - Income Taxes (Details) - Income Tax Expense (Benefit) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2012
Income Tax Expense (Benefit) [Abstract]	'	'	'
Federal	$1,064	($20,627)	'
State	601	-1,124	'
Deferred	-503	'	283
	$1,162	($21,751)	$283

Note_5_Income_Taxes_Details_Ef

Note 5 - Income Taxes (Details) - Effective Tax Rate Reconciliation to Statutory Federal Tax Rate	12 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2012
Effective Tax Rate Reconciliation to Statutory Federal Tax Rate [Abstract]	'	'	'
Tax at federal statutory rate	35.00%	35.00%	35.00%
State taxes, net of federal benefit	17.70%	1.70%	-0.90%
Net non-deductible expenses	-0.60%	'	-5.10%
Non-deductible goodwill impairment charge	'	-9.10%	'
Increase in valuation allowance	-0.90%	-0.30%	-46.40%
Effective tax rate	51.20%	27.30%	-17.40%

Note_5_Income_Taxes_Details_Co

Note 5 - Income Taxes (Details) - Components of Deferred Tax Assets and Deferred Tax Liabilities (USD $)	Mar. 31, 2014	Mar. 31, 2013
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Components of Deferred Tax Assets and Deferred Tax Liabilities [Abstract]	'	'
Stock-based compensation	$2,553	$2,209
Inventory reserve	844	567
Allowance for doubtful accounts	250	333
Accrued expenses	440	720
Net state operating loss carryforwards of acquired company	1,288	1,037
Capital leases	5,483	5,396
	10,858	10,262
Valuation allowance	-1,017	-1,037
Total deferred tax assets	9,841	9,225
Goodwill	8,127	6,356
Depreciation and amortization	6,995	7,874
Total deferred tax liabilities	15,122	14,230
Net deferred tax liability	$5,281	$5,005

Note_5_Income_Taxes_Details_Re

Note 5 - Income Taxes (Details) - Reconciliation of the Beginning and Ending Amount of Unrecognized Tax Benefits, Excluding Interest and Penalties (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013	Mar. 30, 2012
Reconciliation of the Beginning and Ending Amount of Unrecognized Tax Benefits, Excluding Interest and Penalties [Abstract]	'	'	'
Balance	$547	'	$21
Additions based on tax positions taken in the current and prior years	340	526	'
Balance	$887	$547	$21

Note_6_Accrued_Expenses_Detail

Note 6 - Accrued Expenses (Details) - Accrued Expenses (USD $)	Mar. 31, 2014	Mar. 31, 2013
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Note 6 - Accrued Expenses (Details) - Accrued Expenses [Line Items]	'	'
Accrued accounts payable	$6,219	$7,488
Accrued bonuses	4,109	1,825
Employee compensation and benefits	3,025	3,022
Other accrued liabilities	2,291	1,887
Accrued distributor fees	2,011	3,608
Group purchasing organization fees	1,977	1,569
Freight and duty	901	1,270
Professional fees	767	1,178
Commissions	624	768
Book cash overdraft	5,690	5,372
Total accrued expenses	21,924	25,106
Book Cash Overdraft [Member]	'	'
Note 6 - Accrued Expenses (Details) - Accrued Expenses [Line Items]	'	'
Book cash overdraft	'	$2,491

Note_7_Leases_and_Related_Part2

Note 7 - Leases and Related Party Transactions (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2012
	acre	Mar. 31, 2013	Mar. 31, 2012
Note 7 - Leases and Related Party Transactions (Details) [Line Items]	'	'	'
Area of Real Estate Property (in Square Feet)	25	'	'
EffectiveRateOnCapitalLeaseObligation	9.90%	'	'
Capital Leases, Income Statement, Amortization Expense	$614	'	'
Operating Leases, Rent Expense	628	579	488
AVID Facility - Manufacturing and Warehouse Building [Member]	'	'	'
Note 7 - Leases and Related Party Transactions (Details) [Line Items]	'	'	'
Area of Real Estate Property (in Square Feet)	185,000	'	'
AVID Facility - Land [Member]	'	'	'
Note 7 - Leases and Related Party Transactions (Details) [Line Items]	'	'	'
Area of Land (in Acres)	12	'	'
AVID Facility [Member]	'	'	'
Note 7 - Leases and Related Party Transactions (Details) [Line Items]	'	'	'
Capital Lease, Monthly Payment	129	'	'
Increment In Capital Lease Payments Per Year	2.00%	'	'
Selling, General and Administrative [Member]	'	'	'
Note 7 - Leases and Related Party Transactions (Details) [Line Items]	'	'	'
Capital Leases, Income Statement, Amortization Expense	141	'	'
Cost of Sales [Member]	'	'	'
Note 7 - Leases and Related Party Transactions (Details) [Line Items]	'	'	'
Capital Leases, Income Statement, Amortization Expense	$473	'	'

Note_7_Leases_and_Related_Part3

Note 7 - Leases and Related Party Transactions (Details) - Gross and Net Book Value of the Assets Under the Capital Lease (USD $)	Mar. 31, 2014	Mar. 31, 2013
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Gross and Net Book Value of the Assets Under the Capital Lease [Abstract]	'	'
Capital lease, gross	$11,409	$11,409
Less: accumulated amortization	-2,200	-1,586
Capital lease, net	$9,209	$9,823

Note_7_Leases_and_Related_Part4

Note 7 - Leases and Related Party Transactions (Details) - Future Minimum Annual Rental Payments of Non-Cancelable Operating Leases and Capital Leases for Equipment (USD $)	Mar. 31, 2014	Mar. 31, 2013
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Future Minimum Annual Rental Payments of Non-Cancelable Operating Leases and Capital Leases for Equipment [Abstract]	'	'
2015	$1,549	'
2015	1,030	'
2016	1,580	'
2016	791	'
2017	1,611	'
2017	75	'
2018	1,643	'
2018	63	'
2019	1,676	'
2019	30	'
Thereafter	18,722	'
Total minimum lease payments	26,781	'
Total minimum lease payments	1,989	'
Less: Amounts representing interest	-13,310	'
Present value of minimum lease payments	13,471	'
Less: Current portion of capital lease obligations	-226	-176
Long-term portion of capital lease obligations	$13,245	$13,475

Note_7_Leases_and_Related_Part5

Note 7 - Leases and Related Party Transactions (Details) - Custom Healthcare Systems Transactions (Custom Healthcare Systems [Member], USD $)	12 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Custom Healthcare Systems [Member]	'	'
Related Party Transaction [Line Items]	'	'
Sold to CHS	$1,074	$964
Purchased from CHS	1,729	1,861
Due from CHS	330	265
Due to CHS	$14	$45

Note_8_LongTerm_Debt_Details

Note 8 - Long-Term Debt (Details) (USD $)

Mar. 31, 2014

Mar. 31, 2013

Jun. 02, 2014

Dec. 31, 2014

Jun. 02, 2013

Mar. 31, 2014

Jun. 07, 2012

17-May-13

Mar. 31, 2014

17-May-13

Mar. 31, 2014

17-May-13

Mar. 31, 2014

Jun. 07, 2012

Mar. 31, 2014

Jun. 07, 2012

Jun. 02, 2013

Mar. 31, 2014

Jun. 30, 2013

Subsequent Event [Member]

Monthly Amount [Member]

Related To Prior Credit Agreement [Member]

London Interbank Offered Rate (LIBOR) [Member]

"New Credit Agreement" [Member]

"Prior Credit Agreement" [Member]

Minimum [Member]

Maximum [Member]

Measured On A Month-End Basis [Member]

Amended Credit Agreement [Member]

"New Credit Agreement" [Member]

"Prior Credit Agreement" [Member]

Secured Term Loan [Member]

"Delayed Draw Term Loans" [Member]

"Revolving Loans" [Member]

Term Loans Outstanding [Member]

Secured Term Loan [Member]

Revolving Credit Facility [Member]

London Interbank Offered Rate (LIBOR) [Member]

Base Rate [Member]

"New Credit Agreement" [Member]

London Interbank Offered Rate (LIBOR) [Member]

Base Rate [Member]

"New Credit Agreement" [Member]

Minimum [Member]

Maximum [Member]

"Delayed Draw Term Loans" [Member]

Term Loan and Revolving Credit Facility [Member]

"New Credit Agreement" [Member]

"Delayed Draw Term Loans" [Member]

"Revolving Loans" [Member]

Term Loans Outstanding [Member]

"Delayed Draw Term Loans" [Member]

"Revolving Loans" [Member]

Term Loans Outstanding [Member]

"Delayed Draw Term Loans" [Member]

"Revolving Loans" [Member]

Term Loans Outstanding [Member]

"Delayed Draw Term Loans" [Member]

"Revolving Loans" [Member]

Term Loans Outstanding [Member]

"Delayed Draw Term Loans" [Member]

Note 8 - Long-Term Debt (Details) [Line Items]

Line of Credit Facility, Maximum Borrowing Capacity (in Dollars)

$55,000,000

$11,505,000

$5,000,000

$53,495,000

$65,000,000

$51,000,000

$25,000,000

$76,000,000

Debt Instrument, Periodic Payment, Principal (in Dollars)

137,000

Undrawn Commitments Under Credit Facility, Periodic Reduction (in Dollars)

208,000

Debt Instrument, Basis Spread on Variable Rate

4.00%

4.25%

2.00%

2.50%

3.25%

1.00%

1.50%

4.75%

2.50%

3.00%

3.75%

1.50%

2.00%

Line of Credit Facility, Unused Capacity, Commitment Fee Percentage

0.38%

0.50%

Debt, Weighted Average Interest Rate

3.22%

2.86%

Financial Covenant, Minimum Fixed Charge Coverage Ratio

Financial Covenant, Maximum Leverage Financial Ratio

3.25

Line of Credit Facility, Maximum Amount Used to Calculate Commitment Fee (in Dollars)

30,000,000

Deferred Finance Costs, Net (in Dollars)

$1,068,000

$879,000

$216

Line of Credit Facility, Interest Rate During Period

6.25%

4.25%

Note_8_LongTerm_Debt_Details_L

Note 8 - Long-Term Debt (Details) - Long-Term Debt (USD $)	Mar. 31, 2014	Mar. 31, 2013
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Debt Instrument [Line Items]	'	'
Total debt, including current portion	$40,112	$52,700
Less: current portion	40,112	1,370
Total long-term debt	'	51,330
Revolving Credit Facility [Member]	'	'
Debt Instrument [Line Items]	'	'
Total debt, including current portion	29,976	4,700
Secured Term Loan [Member]	'	'
Debt Instrument [Line Items]	'	'
Total debt, including current portion	$10,136	$48,000

Note_9_Fair_Value_Measurements1

Note 9 - Fair Value Measurements (Details) (USD $)	Mar. 31, 2014
In Thousands, unless otherwise specified	Mar. 31, 2014
Fair Value Disclosures [Abstract]	'
Capital Lease Obligations	$13,471
Capital Lease Obligations, Fair Value	$15,479

Note_10_Earnings_Loss_Per_Shar2

Note 10 - Earnings (Loss) Per Share (Details) (Employee Stock Option [Member])	12 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2012
Employee Stock Option [Member]	'	'	'
Note 10 - Earnings (Loss) Per Share (Details) [Line Items]	'	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	1,429,472	1,407,270	1,329,240

Note_10_Earnings_Loss_Per_Shar3

Note 10 - Earnings (Loss) Per Share (Details) - Earnings (Loss) Per Share Reconciliation (USD $)	3 Months Ended								12 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2012
Numerator :	'	'	'	'	'	'	'	'	'	'	'
Income (loss) from continuing operations before extraordinary gain (in Dollars)	'	'	'	'	'	'	'	'	$1,107	($58,054)	($1,917)
Income (loss) from discontinued operations, net of income taxes (Footnote 3) (in Dollars)	'	'	'	'	'	'	'	'	3,085	3,198	1,643
Extraordinary gain (net of tax expense) (Footnote 13) (in Dollars)	'	'	'	'	'	'	'	'	'	'	$455
Net income (loss) for basic and dilutive earnings per share	'	'	'	'	'	'	'	'	$4,192	($54,856)	$181
Denominator :	'	'	'	'	'	'	'	'	'	'	'
Denominator for basic earnings per share - weighted average shares (in Shares)	'	'	'	'	'	'	'	'	16,391	16,391	16,391
Effect of dilutive securities:	'	'	'	'	'	'	'	'	'	'	'
Employee and director stock options (in Shares)	'	'	'	'	'	'	'	'	75	'	'
Denominator for diluted earnings per share - adjusted weighted average shares (in Shares)	'	'	'	'	'	'	'	'	16,466	16,391	16,391
Basic earnings (loss) per share :	'	'	'	'	'	'	'	'	'	'	'
Net income (loss) from continuing operations, before extraordinary gain	'	'	'	'	'	'	'	'	$0.07	($3.54)	($0.12)
Net income from discontinued operations	$0.03	$0.10	$0.05	$0.01	$0.08	$0.06	$0.03	$0.02	$0.19	$0.19	$0.10
Extraordinary gain, net of income taxes	'	'	'	'	'	'	'	'	'	'	$0.03
Net income (loss)	$0.06	$0.12	$0.07	$0.02	$0.04	($3.39)	'	($0.01)	$0.26	($3.35)	$0.01
Diluted earnings (loss) per share :	'	'	'	'	'	'	'	'	'	'	'
Net income (loss) from continuing operations, before extraordinary gain	'	'	'	'	'	'	'	'	$0.07	($3.54)	($0.12)
Net income from discontinued operations	$0.02	$0.10	$0.05	$0.01	$0.08	$0.06	$0.03	$0.02	$0.18	$0.19	$0.10
Extraordinary gain, net of income taxes	'	'	'	'	'	'	'	'	'	'	$0.03
Net income (loss)	$0.05	$0.12	$0.07	$0.02	$0.04	($3.39)	'	($0.01)	$0.25	($3.35)	$0.01

Note_11_Stockholders_Equity_an2

Note 11 - Stockholders' Equity and Stock Plans (Details) (USD $)	12 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2012
Note 11 - Stockholders' Equity and Stock Plans (Details) [Line Items]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value	$1,078,000	'	'
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized	3,083,000	'	'
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition	'1 year 343 days	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value	346,000	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value	0	0	47,000
Employee Stock Option [Member] \| 1989 Non Qualified Option Plan [Member]	'	'	'
Note 11 - Stockholders' Equity and Stock Plans (Details) [Line Items]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent	85.00%	'	'
Employee Stock Option [Member]	'	'	'
Note 11 - Stockholders' Equity and Stock Plans (Details) [Line Items]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Termination Period	'2 months	'	'
Employee Stock Option [Member] \| Minimum [Member]	'	'	'
Note 11 - Stockholders' Equity and Stock Plans (Details) [Line Items]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period	'5 years	'	'
Employee Stock Option [Member] \| Maximum [Member]	'	'	'
Note 11 - Stockholders' Equity and Stock Plans (Details) [Line Items]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period	'10 years	'	'
Restricted Stock [Member]	'	'	'
Note 11 - Stockholders' Equity and Stock Plans (Details) [Line Items]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period	'5 years	'	'
Aggregate Pre Tax Intrinsic Value [Member]	'	'	'
Note 11 - Stockholders' Equity and Stock Plans (Details) [Line Items]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value	$982,000	'	'
1996 Directors Stock Option Plan [Member]	'	'	'
Note 11 - Stockholders' Equity and Stock Plans (Details) [Line Items]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized (in Shares)	7,500	'	'

Note_11_Stockholders_Equity_an3

Note 11 - Stockholders' Equity and Stock Plans (Details) - Change in Restricted Stock Granted Under the 1994 Stock Incentive Plan (Restricted Stock [Member], USD $)	12 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2012
Restricted Stock [Member]	'	'	'
Note 11 - Stockholders' Equity and Stock Plans (Details) - Change in Restricted Stock Granted Under the 1994 Stock Incentive Plan [Line Items]	'	'	'
Beginning Balance	5,625	7,500	7,967
Beginning Balance	$12.58	$12.58	$12.74
Vested	-1,875	-1,875	-467
Vested	$12.58	$12.58	$15.31
Ending Balance	3,750	5,625	7,500
Ending Balance	$12.58	$12.58	$12.58

Note_11_Stockholders_Equity_an4

Note 11 - Stockholders' Equity and Stock Plans (Details) - Assumptions Used to Determine Fair Value of Options Granted (USD $)	12 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2012
Assumptions Used to Determine Fair Value of Options Granted [Abstract]	'	'	'
Expected dividend yield	0.00%	0.00%	0.00%
Expected volatility	63.02%	63.34%	64.44%
Risk-free interest rate	1.04%	1.64%	2.36%
Expected life (years)	'5 years 135 days	'5 years 120 days	'5 years 120 days
Weighted average fair value of options granted (in Dollars per share)	$4.37	$1.99	$2.99

Note_11_Stockholders_Equity_an5

Note 11 - Stockholders' Equity and Stock Plans (Details) - Allocation of Stock-Based Compensation Expense (Before Deferred Income Tax Benefits) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2012
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'	'
Stock-based compensation expense before income tax benefits	$852	$990	$577
Cost of Sales [Member]	'	'	'
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'	'
Stock-based compensation expense before income tax benefits	4	16	11
Selling, General and Administrative Expenses [Member]	'	'	'
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'	'
Stock-based compensation expense before income tax benefits	$848	$974	$566

Note_11_Stockholders_Equity_an6

Note 11 - Stockholders' Equity and Stock Plans (Details) - Stock Options Activity (USD $)	12 Months Ended
In Thousands, except Share data, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2011
Stock Options Activity [Abstract]	'	'	'	'
Number of Options	1,692,750	1,479,000	1,348,437	1,328,937
Weighted Average Exercise Price (in Dollars per share)	$10.12	$10.80	$12.44	$12.62
Granted	511,000	327,500	30,000	'
Granted (in Dollars per share)	$8	$3.58	$5.24	'
Exercised	'	'	-7,500	'
Exercised (in Dollars per share)	'	'	$2.67	'
Forfeited	-297,250	-196,937	-3,000	'
Forfeited (in Dollars per share)	$9.85	$10	$8.87	'
Options outstanding at March 31, 2014	1,692,750	1,479,000	1,348,437	1,328,937
Options outstanding at March 31, 2014 (in Dollars per share)	$10.12	$10.80	$12.44	$12.62
Options outstanding at March 31, 2014	'6 years 73 days	'	'	'
Options outstanding at March 31, 2014 (in Dollars)	$982	'	'	'
Exercisable at March 31, 2014	945,500	'	'	'
Exercisable at March 31, 2014 (in Dollars per share)	$12.18	'	'	'
Exercisable at March 31, 2014	'4 years 109 days	'	'	'
Exercisable at March 31, 2014 (in Dollars)	346	'	'	'
Vested and expected to vest at March 31, 2014	1,606,829	'	'	'
Vested and expected to vest at March 31, 2014	'10 years 98 days	'	'	'
Vested and expected to vest at March 31, 2014	'6 years	'	'	'
Vested and expected to vest at March 31, 2014 (in Dollars)	$928	'	'	'

Note_11_Stockholders_Equity_an7

Note 11 - Stockholders' Equity and Stock Plans (Details) - Summarized Information about Stock Options Outstanding (USD $)	12 Months Ended				12 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2011	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014	Mar. 31, 2013
	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2011	$2.62 To $10.97 [Member]	$2.62 To $10.97 [Member]	$10.98 To $19.36 [Member]	$10.98 To $19.36 [Member]	$19.37 To $23.27 [Member]	$19.37 To $23.27 [Member]	$2.62 To $23.27 [Member]	$2.62 To $23.27 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'	'	'	'	'	'	'	'	'	'	'	'
Range of Exercise Prices per Common Share - Low	'	'	'	'	$2.62	$2.62	$10.98	$10.98	$19.37	$19.37	$2.62	$2.62
Range of Exercise Prices per Common Share - High	'	'	'	'	$10.97	$10.97	$19.36	$19.36	$23.27	$23.27	$23.27	$23.27
Options outstanding (in Shares)	1,692,750	1,479,000	1,348,437	1,328,937	1,022,500,000	724,250,000	573,550,000	640,550,000	96,700,000	114,200,000	1,692,750,000	1,479,000,000
Weighted Average Remaining Contractual Life (Years) - Outstanding	'6 years 73 days	'	'	'	'8 years	'6 years 328 days	'3 years 146 days	'4 years 6 months	'3 years 36 days	'4 years 73 days	'6 years 73 days	'5 years 219 days
Weighted Average Exercise Price Per Common Share - Outstanding	$10.12	$10.80	$12.44	$12.62	$7.38	$7.04	$13.06	$13.11	$21.72	$21.72	$10.12	$10.80
Options - Exercisable (in Shares)	945,500	'	'	'	357,750,000	328,937,000	491,050,000	495,800,000	96,700,000	114,200,000	945,500,000	938,937,000
Weighted Average Exercise Price Per Common Share - Exercisable	$12.18	'	'	'	$8.12	$8.57	$13.26	$13.46	$21.72	$21.72	$12.18	$12.75

Note_11_Stockholders_Equity_an8

Note 11 - Stockholders' Equity and Stock Plans (Details) - Summary of Changes in Non-Vested Stock Options (USD $)	12 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2012
Note 11 - Stockholders' Equity and Stock Plans (Details) - Summary of Changes in Non-Vested Stock Options [Line Items]	'	'	'
Non-vested shares at April 1, 2013	1,479,000	1,348,437	1,328,937
Granted	511,000	327,500	30,000
Granted	$4.37	$1.99	$2.99
Non-vested shares at March 31, 2014	1,692,750	1,479,000	1,348,437
Non-Vested Stock Options [Member]	'	'	'
Note 11 - Stockholders' Equity and Stock Plans (Details) - Summary of Changes in Non-Vested Stock Options [Line Items]	'	'	'
Non-vested shares at April 1, 2013	540,063	'	'
Non-vested shares at April 1, 2013	$4.09	'	'
Granted	511,000	'	'
Granted	$4.37	'	'
Forfeited	-90,000	'	'
Forfeited	$3.11	'	'
Vested	-213,813	'	'
Vested	$5.04	'	'
Non-vested shares at March 31, 2014	747,250	'	'
Non-vested shares at March 31, 2014	$4.13	'	'

Note_11_Stockholders_Equity_an9

Note 11 - Stockholders' Equity and Stock Plans (Details) - Options and Bonus Shares Available for Future Issuance	Mar. 31, 2014
1989 Non Qualified Option Plan [Member] \| Authorized by Directors and Stockholders [Member]	'
Employee Stock Ownership Plan (ESOP) Disclosures [Line Items]	'
Options and Bonus Shares available for future issuance	3,975,000
1989 Non Qualified Option Plan [Member] \| Options Previously Exercised [Member]	'
Employee Stock Ownership Plan (ESOP) Disclosures [Line Items]	'
Options and Bonus Shares available for future issuance	-3,214,687
1989 Non Qualified Option Plan [Member] \| Options Outstanding [Member]	'
Employee Stock Ownership Plan (ESOP) Disclosures [Line Items]	'
Options and Bonus Shares available for future issuance	-436,000
1989 Non Qualified Option Plan [Member] \| Remaining For Future Issuance [Member]	'
Employee Stock Ownership Plan (ESOP) Disclosures [Line Items]	'
Options and Bonus Shares available for future issuance	324,313
1994 Stock Incentive Plan [Member] \| Authorized by Directors and Stockholders [Member]	'
Employee Stock Ownership Plan (ESOP) Disclosures [Line Items]	'
Options and Bonus Shares available for future issuance	3,525,000
1994 Stock Incentive Plan [Member] \| Options Previously Exercised [Member]	'
Employee Stock Ownership Plan (ESOP) Disclosures [Line Items]	'
Options and Bonus Shares available for future issuance	-2,025,187
1994 Stock Incentive Plan [Member] \| Bonus Shares Previously Granted [Member]	'
Employee Stock Ownership Plan (ESOP) Disclosures [Line Items]	'
Options and Bonus Shares available for future issuance	-93,750
1994 Stock Incentive Plan [Member] \| Options Outstanding [Member]	'
Employee Stock Ownership Plan (ESOP) Disclosures [Line Items]	'
Options and Bonus Shares available for future issuance	-1,051,750
1994 Stock Incentive Plan [Member] \| Remaining For Future Issuance [Member]	'
Employee Stock Ownership Plan (ESOP) Disclosures [Line Items]	'
Options and Bonus Shares available for future issuance	354,313
1996 Directors Stock Option Plan [Member] \| Authorized by Directors and Stockholders [Member]	'
Employee Stock Ownership Plan (ESOP) Disclosures [Line Items]	'
Options and Bonus Shares available for future issuance	750,000
1996 Directors Stock Option Plan [Member] \| Options Previously Exercised [Member]	'
Employee Stock Ownership Plan (ESOP) Disclosures [Line Items]	'
Options and Bonus Shares available for future issuance	-100,000
1996 Directors Stock Option Plan [Member] \| Options Outstanding [Member]	'
Employee Stock Ownership Plan (ESOP) Disclosures [Line Items]	'
Options and Bonus Shares available for future issuance	-205,000
1996 Directors Stock Option Plan [Member] \| Remaining For Future Issuance [Member]	'
Employee Stock Ownership Plan (ESOP) Disclosures [Line Items]	'
Options and Bonus Shares available for future issuance	445,000
Authorized by Directors and Stockholders [Member]	'
Employee Stock Ownership Plan (ESOP) Disclosures [Line Items]	'
Options and Bonus Shares available for future issuance	8,250,000
Options Previously Exercised [Member]	'
Employee Stock Ownership Plan (ESOP) Disclosures [Line Items]	'
Options and Bonus Shares available for future issuance	-5,339,874
Bonus Shares Previously Granted [Member]	'
Employee Stock Ownership Plan (ESOP) Disclosures [Line Items]	'
Options and Bonus Shares available for future issuance	-93,750
Options Outstanding [Member]	'
Employee Stock Ownership Plan (ESOP) Disclosures [Line Items]	'
Options and Bonus Shares available for future issuance	-1,692,750
Remaining For Future Issuance [Member]	'
Employee Stock Ownership Plan (ESOP) Disclosures [Line Items]	'
Options and Bonus Shares available for future issuance	1,123,626

Note_12_Retirement_Plans_Detai

Note 12 - Retirement Plans (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2015
				Scenario, Forecast [Member]
				Maximum [Member]
Note 12 - Retirement Plans (Details) [Line Items]	'	'	'	'
Defined Contribution Plan, Employers Matching Contribution, Annual Vesting Percentage	100.00%	'	'	'
Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay	4.00%	'	'	'
Defined Contribution Plan Employer Contribution Vesting Period	'4 years	'	'	'
Defined Contribution Plan, Employer Discretionary Contribution Amount	$771	$789	$690	'
Defined Benefit Plan, Contributions by Employer	'	'	'	125
Defined Benefit Plan, Benefits Paid	$58	$56	'	'

Note_12_Retirement_Plans_Detai1

Note 12 - Retirement Plans (Details) - Planâ€™s Funded Status and Amount Recognized in the Companyâ€™s Financial Statements (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2012
Note 12 - Retirement Plans (Details) - Planâ€™s Funded Status and Amount Recognized in the Companyâ€™s Financial Statements [Line Items]	'	'	'
Fair value of plan assets at beginning of year	$1,143	'	'
Fair value of plan assets at end of year	1,223	1,143	'
Funded status at end of the year	-655	-751	'
Amounts recognized on the balance sheet consist of:	'	'	'
Current liabilities	-655	-751	'
Accumulated other comprehensive loss	651	773	'
Net amount recognized	-4	22	'
Interest cost	76	78	81
Benefits paid	58	56	'
Period Begin [Member]	'	'	'
Note 12 - Retirement Plans (Details) - Planâ€™s Funded Status and Amount Recognized in the Companyâ€™s Financial Statements [Line Items]	'	'	'
Benefit obligation at beginning of year	1,894	1,761	'
Benefit obligation at end of year	'	1,894	'
Fair value of plan assets at beginning of year	1,143	1,029	'
Fair value of plan assets at end of year	'	1,143	'
Amounts recognized on the balance sheet consist of:	'	'	'
Interest cost	76	78	'
Actuarial (gain) loss	-34	111	'
Benefits paid	-58	-56	'
Actual return on plan assets	58	66	'
Employer contributions	80	104	'
Period End [Member]	'	'	'
Note 12 - Retirement Plans (Details) - Planâ€™s Funded Status and Amount Recognized in the Companyâ€™s Financial Statements [Line Items]	'	'	'
Benefit obligation at end of year	1,878	1,894	'
Fair value of plan assets at end of year	$1,223	$1,143	'

Note_12_Retirement_Plans_Detai2

Note 12 - Retirement Plans (Details) - Major Categories of Assets Held By the Plan, Measured At Level 1 Fair Value (USD $)	Mar. 31, 2014	Mar. 31, 2013
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Note 12 - Retirement Plans (Details) - Major Categories of Assets Held By the Plan, Measured At Level 1 Fair Value [Line Items]	'	'
Plan asset categories	$1,223	$1,143
Cash and Cash Equivalents [Member] \| Fair Value, Inputs, Level 1 [Member]	'	'
Note 12 - Retirement Plans (Details) - Major Categories of Assets Held By the Plan, Measured At Level 1 Fair Value [Line Items]	'	'
Plan asset categories	'	23
Cash and Cash Equivalents [Member] \| Fair Value, Inputs, Level 2 [Member]	'	'
Note 12 - Retirement Plans (Details) - Major Categories of Assets Held By the Plan, Measured At Level 1 Fair Value [Line Items]	'	'
Plan asset categories	24	'
Cash and Cash Equivalents [Member]	'	'
Note 12 - Retirement Plans (Details) - Major Categories of Assets Held By the Plan, Measured At Level 1 Fair Value [Line Items]	'	'
Plan asset categories	24	23
Debt Securities [Member] \| Fair Value, Inputs, Level 1 [Member]	'	'
Note 12 - Retirement Plans (Details) - Major Categories of Assets Held By the Plan, Measured At Level 1 Fair Value [Line Items]	'	'
Plan asset categories	'	402
Debt Securities [Member] \| Fair Value, Inputs, Level 2 [Member]	'	'
Note 12 - Retirement Plans (Details) - Major Categories of Assets Held By the Plan, Measured At Level 1 Fair Value [Line Items]	'	'
Plan asset categories	432	'
Debt Securities [Member]	'	'
Note 12 - Retirement Plans (Details) - Major Categories of Assets Held By the Plan, Measured At Level 1 Fair Value [Line Items]	'	'
Plan asset categories	432	402
Equity Securities [Member] \| Fair Value, Inputs, Level 2 [Member]	'	'
Note 12 - Retirement Plans (Details) - Major Categories of Assets Held By the Plan, Measured At Level 1 Fair Value [Line Items]	'	'
Plan asset categories	767	718
Equity Securities [Member]	'	'
Note 12 - Retirement Plans (Details) - Major Categories of Assets Held By the Plan, Measured At Level 1 Fair Value [Line Items]	'	'
Plan asset categories	767	718
Fair Value, Inputs, Level 1 [Member]	'	'
Note 12 - Retirement Plans (Details) - Major Categories of Assets Held By the Plan, Measured At Level 1 Fair Value [Line Items]	'	'
Plan asset categories	'	425
Fair Value, Inputs, Level 2 [Member]	'	'
Note 12 - Retirement Plans (Details) - Major Categories of Assets Held By the Plan, Measured At Level 1 Fair Value [Line Items]	'	'
Plan asset categories	$1,223	$718

Note_12_Retirement_Plans_Detai3

Note 12 - Retirement Plans (Details) - Net Periodic Pension Cost (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2012
Net Periodic Pension Cost [Abstract]	'	'	'
Interest cost on projected benefit obligation	$76	$78	$81
Expected investment income	-70	-64	-59
Net amortization and deferral	64	53	26
Net periodic pension cost	$70	$67	$48

Note_12_Retirement_Plans_Detai4

Note 12 - Retirement Plans (Details) - Weighted-Average Assumptions Used To Determine Benefit Obligations	Mar. 31, 2014	Mar. 31, 2013
Weighted-Average Assumptions Used To Determine Benefit Obligations [Abstract]	'	'
Discount rate	4.25%	4.07%
Rate of compensation increase	0.00%	0.00%

Note_12_Retirement_Plans_Detai5

Note 12 - Retirement Plans (Details) - Weighted-Average Assumptions Used To Determine Net Periodic Benefit Cost	12 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Weighted-Average Assumptions Used To Determine Net Periodic Benefit Cost [Abstract]	'	'
Discount rate	4.07%	4.49%
Expected long-term return on plan assets	6.00%	6.00%
Rate of compensation increase	0.00%	0.00%

Note_12_Retirement_Plans_Detai6

Note 12 - Retirement Plans (Details) - Weighted-Average Asset Allocation by Asset Category	12 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Cash [Member]	'	'
Note 12 - Retirement Plans (Details) - Weighted-Average Asset Allocation by Asset Category [Line Items]	'	'
Low Target Range	0.00%	'
High Target Range	20.00%	'
Actual plan asset allocations	2.00%	2.00%
Debt Securities [Member]	'	'
Note 12 - Retirement Plans (Details) - Weighted-Average Asset Allocation by Asset Category [Line Items]	'	'
Low Target Range	10.00%	'
High Target Range	70.00%	'
Actual plan asset allocations	63.00%	63.00%
Equity Securities [Member]	'	'
Note 12 - Retirement Plans (Details) - Weighted-Average Asset Allocation by Asset Category [Line Items]	'	'
Low Target Range	30.00%	'
High Target Range	90.00%	'
Actual plan asset allocations	35.00%	35.00%
Total [Member]	'	'
Note 12 - Retirement Plans (Details) - Weighted-Average Asset Allocation by Asset Category [Line Items]	'	'
Actual plan asset allocations	100.00%	100.00%

Note_12_Retirement_Plans_Detai7

Note 12 - Retirement Plans (Details) - Future Benefit Payments Under the Plan (USD $)	Mar. 31, 2014
In Thousands, unless otherwise specified	Mar. 31, 2014
Future Benefit Payments Under the Plan [Abstract]	'
2015	$60
2016	67
2017	71
2018	74
2019	77
2020 - 2023	527
	$876

Note_13_Extraordinary_Items_De

Note 13 - Extraordinary Items (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2012
Extraordinary and Unusual Items [Abstract]	'
Extraordinary Item, Gain (Loss), Net of Tax, Attributable to Parent	$455
Income Tax Expense (Benefit), Extraordinary Items	$245

Note_14_Other_Matters_Details

Note 14 - Other Matters (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014
	acre
Note 14 - Other Matters (Details) [Line Items]	'
Change in Control of Beneficial Ownership	20.00%
Executive Termination Severance Payment Multiplier	2.99
Area of Real Estate Property (in Acres)	25
Loss Contingency Accrual	$4,200
Future Event December 7, 2014 Through December 7, 2017 [Member] \| Indemnitor [Member]	'
Note 14 - Other Matters (Details) [Line Items]	'
Letters of Credit Outstanding, Amount	1,000
Indemnitor [Member]	'
Note 14 - Other Matters (Details) [Line Items]	'
Letters of Credit Outstanding, Amount	2,000
Seven Executive Officers and a Vice President [Member] \| Employee Severance [Member]	'
Note 14 - Other Matters (Details) [Line Items]	'
Employee-related Liabilities	$12,556

Note_15_Subsequent_Events_Deta

Note 15 - Subsequent Events (Details) (USD $)	0 Months Ended	1 Months Ended	0 Months Ended		7 Months Ended	0 Months Ended
In Thousands, unless otherwise specified	Jun. 02, 2014	Jun. 30, 2014	Jun. 02, 2014	Jun. 02, 2014	Dec. 31, 2014	Jun. 02, 2014	17-May-13
	Subsequent Event [Member]	Subsequent Event [Member]	Subsequent Event [Member]	Subsequent Event [Member]	Subsequent Event [Member]	Subsequent Event [Member]	"New Credit Agreement" [Member]
	Medegen Medical Products [Member]	Medegen Medical Products [Member]	Term Loan and Revolving Credit Facility [Member]	Amended Credit Agreement [Member]	Amended Credit Agreement [Member]	Working Capital [Member]
Note 15 - Subsequent Events (Details) [Line Items]	'	'	'	'	'	'	'
Percentage Of Ownership Sold	100.00%	'	'	'	'	'	'
Proceeds from Divestiture of Businesses	$78,628	$78,628	'	'	'	$38,628	'
Repayments of Debt	'	'	40,000	'	'	'	'
Line of Credit Facility, Maximum Borrowing Capacity	'	'	'	55,000	'	'	65,000
Line of Credit Facility, Unused Capacity, Commitment Fee Percentage	'	'	'	0.38%	0.38%	'	'
Line of Credit Facility, Maximum Amount Used to Calculate Commitment Fee	'	'	'	$30,000	$30,000	'	'

Note_16_Summary_of_Unaudited_Q2

Note 16 - Summary of Unaudited Quarterly Financial Data (Details) - Quarterly Financial Data of the Company (USD $)	3 Months Ended								12 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2012
Quarterly Financial Data of the Company [Abstract]	'	'	'	'	'	'	'	'	'	'	'
Net sales (in Dollars)	$72,482	$72,521	$71,320	$71,526	$69,369	$72,824	$72,393	$70,177	$287,849	$284,763	$272,734
Gross profit (in Dollars)	14,465	13,896	13,271	13,384	12,759	13,558	12,366	12,214	55,016	50,897	44,125
Income after income taxes	'	'	'	'	'	'	'	'	'	'	'
Continuing operations (in Dollars)	507	305	205	90	-624	-56,536	-507	-387	2,269	-79,805	-1,634
Discontinued operations (in Dollars)	397	1,606	893	189	1,343	1,033	572	250	'	'	'
Net income (in Dollars)	$904	$1,911	$1,098	$279	$719	($55,503)	$65	($137)	$4,192	($54,856)	$181
Basic earnings per common share:	'	'	'	'	'	'	'	'	'	'	'
Net income from continuing operations	$0.03	$0.02	$0.02	$0.01	($0.04)	($3.45)	($0.03)	($0.03)	'	'	'
Net income from discontinued operations	$0.03	$0.10	$0.05	$0.01	$0.08	$0.06	$0.03	$0.02	$0.19	$0.19	$0.10
Total	$0.06	$0.12	$0.07	$0.02	$0.04	($3.39)	'	($0.01)	$0.26	($3.35)	$0.01
Diluted earnings per common share:	'	'	'	'	'	'	'	'	'	'	'
Net income from continuing operations	$0.03	$0.02	$0.02	$0.01	($0.04)	($3.45)	($0.03)	($0.03)	'	'	'
Net income from discontinued operations	$0.02	$0.10	$0.05	$0.01	$0.08	$0.06	$0.03	$0.02	$0.18	$0.19	$0.10
Total	$0.05	$0.12	$0.07	$0.02	$0.04	($3.39)	'	($0.01)	$0.25	($3.35)	$0.01

Schedule_II_Valuation_and_Qual1

Schedule II - Valuation and Qualifying Accounts (Details) - Valuation and Qualifying Accounts (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014		Mar. 31, 2013		Mar. 31, 2012
Schedule II - Valuation and Qualifying Accounts (Details) - Valuation and Qualifying Accounts [Line Items]	'		'		'
Balance at Beginning of Year	$2,921		$2,554		$2,219
Gross Amount Charged to Cost and Expenses	699		831		1,082
Other Charges/ (Deductions)	-363		-464		-747
Balance at End of Year	2,471		2,921		2,554
Charged to Other Accounts	-786		'		'
Allowance for Doubtful Accounts [Member]	'		'		'
Schedule II - Valuation and Qualifying Accounts (Details) - Valuation and Qualifying Accounts [Line Items]	'		'		'
Balance at Beginning of Year	793		781		804
Gross Amount Charged to Cost and Expenses	-292		12		72
Other Charges/ (Deductions)	'		'		-95	[1]
Balance at End of Year	501		793		781
Inventory Valuation Reserve [Member]	'		'		'
Schedule II - Valuation and Qualifying Accounts (Details) - Valuation and Qualifying Accounts [Line Items]	'		'		'
Balance at Beginning of Year	1,091		1,015		1,415
Gross Amount Charged to Cost and Expenses	1,011		540		252
Other Charges/ (Deductions)	-363	[2]	-464	[2]	-652	[2]
Balance at End of Year	953		1,091		1,015
Charged to Other Accounts	-786	[3]	'		'
Valuation Allowance of Deferred Tax Assets [Member]	'		'		'
Schedule II - Valuation and Qualifying Accounts (Details) - Valuation and Qualifying Accounts [Line Items]	'		'		'
Balance at Beginning of Year	1,037		758		'
Gross Amount Charged to Cost and Expenses	-20		279		758
Balance at End of Year	$1,017		$1,037		$758

[1]	Write off of uncollected accounts
[2]	Disposal of slow moving and obsolete inventory
[3]	Represents amounts related to assets held for sale